| EOS-AX8963 | 2-2-Dimethyl Succinic acid | 597-43-3 | C6H10O4 | 146.14 | CC(CC(O)=O)(C(O)=O)C |
| EOS-AX8964 | 2-3-Dihydroxybenzoic acid | 303-38-8 | C7H6O4 | 154.12 | OC1=CC=CC(C(O)=O)=C1O |
| EOS-AX8965 | 2-3-Pyridinedicarboxylic acid | 339155-13-4 | C7H5NO4 | 167.12 | O=C(O)C(C=CC=N1)=C1C(O)=O |
| EOS-AX8966 | 2-4-Quinolinediol | 86-95-3 | C9H7NO2 | 161.16 | OC1=CC(O)=NC2=CC=CC=C21 |
| EOS-AX8967 | 2-Deoxyadenosine | 958-09-8 | C10H13N5O3+adduct | 251.24 | NC1=C(N=CN2[C@@]3([H])C[C@@](O)([H])[C@@](O3)([H])CO)C2=NC=N1 |
| EOS-AX8968 | 2-Deoxyadenosine 5-diphosphate | 72003-83-9 | C10H15N5O9P2 | 411.2 | NC1=C(N=CN2[C@@]3([H])C[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(O)=O)=O)C2=NC=N1 |
| EOS-AX8969 | 2-Deoxycytidine | 951-77-9 | C9H13N3O4+adduct | 227.22 | N=C1C=CN(C(O)=N1)[C@@]2([H])C[C@@](O)([H])[C@@](O2)([H])CO |
| EOS-AX8970 | 2-Deoxycytidine 5-monophosphate | 1032-65-1 | C9H14N3O7P | 307.2 | N=C1C=CN(C(O)=N1)[C@@]2([H])C[C@@](O)([H])[C@@](O2)([H])COP(O)(O)=O |
| EOS-AX8971 | 2-Deoxy-D-ribose | 533-67-5 | C5H10O4+adduct | 134.13 | O=CC[C@@](O)([H])[C@@](O)([H])CO |
| EOS-AX8972 | 2-Deoxyinosine | 890-38-0 | C10H12N4O4 | 252.23 | OC[C@](O1)([H])[C@](O)([H])C[C@]1([H])N2C=NC3=C2N=CN=C3O |
| EOS-AX8973 | 2-Deoxyuridine | 951-78-0 | C9H12N2O5 | 228.2 | OC[C@](O1)([H])[C@](O)([H])C[C@]1([H])N2C=CC(O)=NC2=O |
| EOS-AX8974 | 3-Hydroxyphenylacetic acid | 621-37-4 | C8H8O3 | 152.15 | OC1=CC=CC(CC(O)=O)=C1 |
| EOS-AX8975 | 3-Methylglutaric acid | 626-51-7 | C6H10O4 | 146.14 | CC(CC(O)=O)CC(O)=O |
| EOS-AX8976 | 4-Aminobenzoic acid | 150-13-0 | C7H7NO2 | 137.14 | NC1=CC=C(C(O)=O)C=C1 |
| EOS-AX8977 | 4-Hydroxybenzoic acid | 99-96-7 | C7H6O3 | 138.12 | OC1=CC=C(C(O)=O)C=C1 |
| EOS-AX8978 | 4-quinolinol | 611-36-9 | C9H7NO | 145.16 | O=C1C=CNC2=CC=CC=C21 |
| EOS-AX8979 | 5-Methoxytryptamine | 608-07-1 | C11H14N2O | 190.24 | COC1=CC(C(CCN)=CN2)=C2C=C1 |
| EOS-AX8980 | 6-Hydroxynicotinic acid | 5006-66-6 | C6H5NO3 | 139.11 | OC1=NC=C(C(O)=O)C=C1 |
| EOS-AX8981 | Adenosine 3-5-cyclic monophosphate | 60-92-4 | C10H12N5O6P | 329.21 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O4)([H])[C@@](O3)([H])COP4(O)=O)C2=NC=N1 |
| EOS-AX8982 | Adenosine 5-monophosphate | 61-19-8 | C10H14N5O7P | 347.22 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(O)=O)C2=NC=N1 |
| EOS-AX8983 | Adenosine 5-triphosphate | 34369-07-8 | C10H16N5O13P3 | 507.18 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O)C2=NC=N1 |
| EOS-AX8984 | beta-Nicotinamide adenine dinucleotide | 606-68-8 | C21H28N7O14P2 | 664.43 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(OC[C@](O4)([H])[C@](O)([H])[C@](O)([H])[C@]4([H])[N+]5=CC=CC(C(O)=N)=C5)=O)=O)C2=NC=N1 |
| EOS-AX8985 | beta-Nicotinamide mononucleotide | 1094-61-7 | C11H16N2O8P | 334.22 | N=C(O)C1=C[N+]([C@@]2([H])[C@@](O)([H])[C@@](O)([H])[C@@](O2)([H])COP(O)([O-])=O)=CC=C1 |
| EOS-AX8986 | Cellobiose | 528-50-7 | C12H22O11 | 342.3 | OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@@](O[C@]([C@@](O)([H])[C@](O)([H])[C@]2([H])O)([H])[C@@](O2)([H])CO)([H])O1 |
| EOS-AX8987 | Cytidine 5-triphosphate | 65-47-4 | C9H16N3O14P3 | 483.16 | N=C1C=CN(C(O)=N1)[C@@]2([H])[C@@](O)([H])[C@@](O)([H])[C@@](O2)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O |
| EOS-AX8988 | D-+-Galactosamine | 1772-03-8 | C6H13NO5+adduct | 215.63 | N[C@@]([C@](O)([H])[C@](O)([H])[C@@](O)([H])CO)([H])C=O.Cl |
| EOS-AX8989 | Deoxyadenosine 5-triphosphate | 1927-31-7 | C10H16N5O12P3 | 491.18 | NC1=C(N=CN2[C@@]3([H])C[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O)C2=NC=N1 |
| EOS-AX8990 | Deoxyguanosine 5-triphosphate | 93919-41-6 | C10H16N5O13P3 | 507.18 | O=P(OP([O-])(OP([O-])(OC[C@H]1O[C@@H](N2C=NC3=C2NC(N)=NC3=O)C[C@@H]1O)=O)=O)([O-])O.[Na+].[Na+].[Na+] |
| EOS-AX8991 | D-Maltose | 133-99-3 | C12H22O11 | 342.3 | OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@@](O[C@]([C@@](O)([H])[C@](O)([H])C2([H])O)([H])[C@@](O2)([H])CO)([H])O1 |
| EOS-AX8992 | Flavin adenine dinucleotide | 146-14-5 | C27H33P2N9O15 | 785.55 | CC1=CC(N=C(C(O)=N2)C3=NC2=O)=C(N3C[C@@](O)([H])[C@@](O)([H])[C@@](O)([H])COP(O)(OP(O)(OC[C@](O4)([H])[C@](O)([H])[C@](O)([H])[C@]4([H])N5C=NC(C5=NC=N6)=C6N)=O)=O)C=C1C |
| EOS-AX8993 | Folinic acid | 58-05-9 | C20H23N7O7 | 473.44 | N=C1NC(NCC(N2C=O)([H])CNC3=CC=C(C(N[C@@](C(O)=O)([H])CCC(O)=O)=O)C=C3)=C2C(O)=N1 |
| EOS-AX8994 | gamma-Glu-Cys | 636-58-8 | C8H14N2O5S | 250.27 | N[C@@](C(O)=O)([H])CC/C(O)=N/[C@@](C(O)=O)([H])CS |
| EOS-AX8995 | Glyoxylic acid | 298-12-4 | C2H2O3 | 74.04 | O=CC(O)=O |
| EOS-AX8996 | Guanine | 73-40-5 | C5H5N5O | 151.13 | N=C1NC2=C(N=CN2)C(O)=N1 |
| EOS-AX8997 | Isopentyl acetate | 123-92-2 | C7H14O2 | 130.18 | CC(CCOC(C)=O)C |
| EOS-AX8998 | Itaconic acid | 97-65-4 | C5H6O4 | 130.1 | C=C(C(O)=O)CC(O)=O |
| EOS-AX8999 | Ketoisovaleric acid | 759-05-7 | C5H8O3 | 116.12 | CC(C(C(O)=O)=O)C |
| EOS-AX9000 | Lactic acid | 50-21-5 | C3H6O3 | 90.08 | CC(O)C(O)=O |
| EOS-AX9001 | L-Arabinose | 5328-37-0 | C5H10O5 | 150.13 | O[C@@]1([H])COC(O)([H])[C@@](O)([H])[C@@]1([H])O |
| EOS-AX9002 | L-Arabitol | 7643-75-6 | C5H12O5 | 152.15 | OC[C@@](O)([H])C(O)[C@](O)([H])CO |
| EOS-AX9003 | L-Dihydroorotic acid | 5988-19-2 | C5H6N2O4 | 158.11 | OC1=NC(O)=N[C@@](C(O)=O)([H])C1 |
| EOS-AX9004 | L-homocystine | 462-10-2 | C8H16N2O4S | 268.35 | NC(C(O)=O)CCSSCCC(N)C(O)=O |
| EOS-AX9005 | Lipoamide | 940-69-2 | C8H15NOS2 | 205.34 | N=C(O)CCCCC1CCSS1 |
| EOS-AX9006 | L-Sorbose | 87-79-6 | C6H12O6 | 180.16 | OC[C@@](O)([H])[C@](O)([H])[C@@](O)([H])C(CO)=O |
| EOS-AX9007 | Malonic acid | 141-82-2 | C3H4O4 | 104.06 | O=C(O)CC(O)=O |
| EOS-AX9008 | Melibiose | 585-99-9 | C12H22O11 | 342.3 | O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])CO[C@]1([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@@](O1)([H])CO |
| EOS-AX9009 | m-Hydroxybenzoic acid | 99-06-9 | C7H6O3 | 138.12 | OC1=CC=CC(C(O)=O)=C1 |
| EOS-AX9010 | myo-Inositol | 87-89-8 | C6H12O6+adduct | 180.16 | OC1C(O)C(O)C(O)C(O)C1O |
| EOS-AX9011 | N-acetyl D-galactosamine | 1811-31-0 | C8H15NO6 | 221.21 | C/C(O)=N/[C@@]([C@](O)([H])[C@](O)([H])[C@@](O)([H])CO)([H])C=O |
| EOS-AX9012 | N-Acetylneuraminic acid | 131-48-6 | C11H19NO9 | 309.27 | C/C(O)=N/[C@]([C@](O1)([H])[C@@](O)([H])[C@@](O)([H])CO)([H])[C@](O)([H])C[C@@]1(O)C(O)=O |
| EOS-AX9013 | N-carbamoyl-DL-aspartic acid | 923-37-5 | C5H8N2O5 | 176.13 | N=C(O)NC(C(O)=O)CC(O)=O |
| EOS-AX9014 | N-Carbamyl-L-glutamic acid | 1188-38-1 | C6H10N2O5 | 190.15 | N=C(O)N[C@@](C(O)=O)([H])CCC(O)=O |
| EOS-AX9015 | O-Phosphorylethanolamine | 1071-23-4 | C2H8NO4P | 141.06 | NCCOP(O)(O)=O |
| EOS-AX9016 | Oxamic acid | 471-47-6 | C2H3NO3 | 89.05 | NC(C(O)=O)=O |
| EOS-AX9017 | Pyridoxal 5 phosphate | 54-47-7 | C8H10NO6P | 247.14 | CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1 |
| EOS-AX9018 | Pyridoxal hydrochloride | 65-22-5 | C8H9NO3 | 203.62 | CC1=C(O)C(C=O)=C(CO)C=N1.Cl |
| EOS-AX9019 | Pyridoxine | 65-23-6 | C8H11NO3 | 169.18 | CC1=C(O)C(CO)=C(CO)C=N1 |
| EOS-AX9020 | Ribonic acid gamma lactone | 5336-08-3 | C5H8O5 | 148.11 | OC[C@](O1)([H])[C@](O)([H])[C@](O)([H])C1=O |
| EOS-AX9021 | trans-Aconitic acid | 4023-65-8 | C6H6O6 | 174.11 | O=C(O)/C([H])=C(C(O)=O)\CC(O)=O |
| EOS-AX9022 | trans-trans Muconic acid | 3588-17-8 | C6H6O4 | 142.11 | O=C(O)/C([H])=C([H])/C([H])=C([H])/C(O)=O |
| EOS-AX9023 | Trehalose | 99-20-7 | C12H22O11 | 342.3 | OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@](O[C@]2([H])[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O2)([H])CO)([H])O1 |
| EOS-AX9024 | Vanillic acid | 121-34-6 | C8H8O4 | 168.15 | COC1=C(O)C=CC(C(O)=O)=C1 |
| EOS-AX9025 | 2-(4-Hydroxyphenylazo)benzoic acid | 1634-82-8 | C13H10N2O3 | 242.23 | O=C1C=C/C(C=C1)=N/NC2=CC=CC=C2C(O)=O |
| EOS-AX9026 | GSK864 | 1816331-66-4 | C30H31FN6O4 | 558.6 | O=C(C1=NN(C2=C1CN(C[C@@]2(C(N)=O)C)C(C3=CC=CN3)=O)CC4=CC=C(C=C4)F)NC5=CC(C)=C(C(C)=C5)OC |
| EOS-AX9027 | SKL2001 | 909089-13-0 | C14H14N4O3 | 286.29 | O=C(C1=NOC(C2=CC=CO2)=C1)NCCCN3C=CN=C3 |
| EOS-AX9028 | 3-Bromopyruvic acid | 1113-59-3 | C3H3BrO3 | 166.96 | BrCC(C(O)=O)=O |
| EOS-AX9029 | GNE-493 | 1033735-94-2 | C17H20N6O2S | 372.44 | OC(C)(C)C1=CC(N=C(C2=CN=C(N)N=C2)N=C3N4CCOCC4)=C3S1 |
| EOS-AX9030 | GNE-477 | 1032754-81-6 | C21H28N8O3S2 | 504.63 | O=S(N1CCN(CC2=C(C)C3=NC(C4=CN=C(N)N=C4)=NC(N5CCOCC5)=C3S2)CC1)(C)=O |
| EOS-AX9031 | LY2857785 | 1619903-54-6 | C26H36N6O | 448.6 | CN1C(C(C)C)=C(C(C=C2)=N1)C=C2C3=NC(N[C@H]4CC[C@H](NC5CCOCC5)CC4)=NC=C3 |
| EOS-AX9032 | WH-4-023 | 837422-57-8 | C32H36N6O4 | 568.67 | CN1CCN(C2=CC=C(NC3=NC(N(C4=CC=C(OC)C=C4OC)C(OC5=C(C)C=CC=C5C)=O)=CC=N3)C=C2)CC1 |
| EOS-AX9033 | SB269652 | 215802-15-6 | C27H30N4O | 426.55 | N#CC1=CC=C2C(CN(CC[C@H]3CC[C@H](NC(C4=CC5=C(C=CC=C5)N4)=O)CC3)CC2)=C1 |
| EOS-AX9034 | GSK2194069 | 1332331-08-4 | C25H24N4O3 | 428.48 | O=C1NN=C(C[C@@H]2CCN(C(C3CC3)=O)C2)N1C4=CC=C(C5=CC=C(OC=C6)C6=C5)C=C4 |
| EOS-AX9035 | c-di-AMP | 54447-84-6 | C20H24N10O12P2 | 658.41 | NC1=C2C(N([C@@H]3O[C@@]([H])(COP4(O)=O)[C@@]([H])(OP(OC[C@@]5([H])[C@]([H])([C@H](O)[C@H](N6C7=NC=NC(N)=C7N=C6)O5)O4)(O)=O)C3O)C=N2)=NC=N1 |
| EOS-AX9036 | G-749 | 1457983-28-6 | C25H25BrN6O2 | 521.41 | |
| EOS-AX9037 | UNC0379 | 1620401-82-2 | C23H35N5O2 | 413.56 | COC1=C(C=C(N=C(N2CCCC2)N=C3NCCCCCN4CCCC4)C3=C1)OC |
| EOS-AX9038 | NIBR189 | 1599432-08-2 | C21H21BrN2O3 | 429.31 | BrC1=CC=C(/C=C/C(N2CCN(C(C3=CC=C(OC)C=C3)=O)CC2)=O)C=C1 |
| EOS-AX9039 | GK921 | 1025015-40-0 | C21H20N4O | 344.41 | C12=NC=CC=C1N=C(OCCN3CCCC3)C(C#CC4=CC=CC=C4)=N2 |
| EOS-AX9040 | ON 146040 | 1404231-34-0 | C24H23N7O3S | 489.55 | O=C(NC(C=NC(NC1=CC=C(N2CCN(C)CC2)C=C1)=N3)=C3S/4)C4=C\C5=CC=C([N+]([O-])=O)C=C5 |
| EOS-AX9041 | NVS-CRF38 | 1207258-55-6 | C19H21N5O2 | 351.4 | CC1=NN(C2=C3N(C(C4=C(C)C=C(OC)C=C4)=C(C)O3)N=C2C)C(C)=N1 |
| EOS-AX9042 | ML355 | 1532593-30-8 | C21H19N3O4S2 | 441.52 | O=S(NC1=NC2=CC=CC=C2S1)(C(C=C3)=CC=C3NCC4=CC=CC(OC)=C4O)=O |
| EOS-AX9043 | ML216 | 1430213-30-1 | C15H9F4N5OS | 383.32 | FC(C(C(F)(F)F)=C1)=CC=C1NC(NC2=NN=C(C3=CC=NC=C3)S2)=O |
| EOS-AX9044 | UNC2025 | 1429881-91-3 | C28H40N6O | 476.66 | CN1CCN(CC2=CC=C(C3=CN([C@@H]4CC[C@@H](O)CC4)C5=NC(NCCCC)=NC=C35)C=C2)CC1 |
| EOS-AX9045 | ML365 | 947914-18-3 | C22H20N2O3 | 360.41 | O=C(C1=CC=CC(C)=C1)NC2=CC=CC(NC(C3=CC=CC=C3OC)=O)=C2 |
| EOS-AX9046 | PF 1022A | 133413-70-4 | C52H76N4O12 | 949.18 | O=C([C@@H](CC1=CC=CC=C1)OC([C@H](CC(C)C)N(C)C2=O)=O)N(C)[C@H](C(O[C@H](C)C(N(C)[C@H](C(O[C@H](CC3=CC=CC=C3)C(N(C)[C@H](C(O[C@@H]2C)=O)CC(C)C)=O)=O)CC(C)C)=O)=O)CC(C)C |
| EOS-AX9047 | Pimavanserin | 706779-91-1 | C25H34FN3O2 | 427.55 | FC1=CC=C(C=C1)CN(C(NCC(C=C2)=CC=C2OCC(C)C)=O)C3CCN(C)CC3 |
| EOS-AX9048 | D8-MMAE | | C39H59D8N5O7 | 726.03 | C[C@@H](NC([C@H](C)[C@@H](OC)[C@H]1N(C(C[C@@H](OC)[C@@H](N(C)C([C@@]([2H])(C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])NC([C@@H](C(C)C)NC)=O)=O)[C@@H](C)CC)=O)CCC1)=O)[C@@H](O)C2=CC=CC=C2 |
| EOS-AX9049 | GS-7340 | 379270-37-8 | C21H29N6O5P | 476.47 | O=[P@@](N[C@H](C(OC(C)C)=O)C)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)OC3=CC=CC=C3 |
| EOS-AX9050 | GS-7340 fumarate | 379270-38-9 | C25H33N6O9P | 592.54 | NC1=NC=NC2=C1N=CN2C[C@@H](C)OC[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O.OC(/C=C/C(O)=O)=O |
| EOS-AX9051 | Cerdulatinib (PRT062070) | 1198300-79-6 | C20H27N7O3S | 445.54 | NC(C1=CN=C(NC2=CC=C(N3CCN(S(=O)(CC)=O)CC3)C=C2)N=C1NC4CC4)=O |
| EOS-AX9052 | Tolfenpyrad | 129558-76-5 | C21H22ClN3O2 | 383.87 | ClC1=C(C(NCC(C=C2)=CC=C2OC3=CC=C(C)C=C3)=O)N(C)N=C1CC |
| EOS-AX9053 | Tiadinil | 223580-51-6 | C11H10ClN3OS | 267.73 | CC1=CC=C(NC(C2=C(C)N=NS2)=O)C=C1Cl |
| EOS-AX9054 | Valifenalate | 283159-90-0 | C19H27ClN2O5 | 398.88 | ClC1=CC=C(C=C1)[C@H](CC(OC)=O)NC([C@H](C(C)C)NC(OC(C)C)=O)=O |
| EOS-AX9055 | Penthiopyrad | 183675-82-3 | C16H20F3N3OS | 359.41 | FC(F)(C1=NN(C)C=C1C(NC2=C([C@@H](C)CC(C)C)SC=C2)=O)F |
| EOS-AX9056 | Pyraclonil | 158353-15-2 | C15H15ClN6 | 314.77 | ClC1=C(CCCC2)N2N=C1N3N=CC(C#N)=C3N(C)CC#C |
| EOS-AX9057 | ARN2966 | 102212-26-0 | C12H12N2O | 200.24 | OC1=CC=CC=C1NCC2=NC=CC=C2 |
| EOS-AX9058 | 6-O-α-Maltosyl-β-cyclodextrin | 104723-60-6 | C54H90O45 | 1459.27 | OC[C@H]1OC(O[C@H]2[C@H](O)[C@@H](O)[C@@H](O3)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O[C@@H]4O[C@H](CO)[C@@H](O[C@H]5O[C@H](CO)[C@H](O[C@H]6O[C@H](CO[C@@H]7[C@H](O)[C@@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]8O)[C@@H](CO)O7)[C@H](O[C@H]9O[C@H](CO)[ |
| EOS-AX9059 | MK-571 sodium salt hydrate | 115103-85-0 | C26H26ClN2NaO3S2·xH2O | 537.07 (anhydrous ba | |
| EOS-AX9060 | SB 225002 | 182498-32-4 | C13H10BrN3O4 | 352.14 | OC1=C(NC(NC2=CC=CC=C2Br)=O)C=CC([N+]([O-])=O)=C1 |
| EOS-AX9061 | 8-Bromo-cAMP, sodium salt | 76939-46-3 | C10H10BrN5NaO6P | 430.09 | NC1=C(N=C(Br)N2[C@@H]3O[C@H](COP(O4)([O-])=O)[C@@H]4[C@H]3O)C2=NC=N1.[Na+] |
| EOS-AX9062 | Dibutyryl-cAMP, sodium salt | 16980-89-5 | C18H23N5NaO8P | 491.37 | CCCC(NC1=NC=NC2=C1N=CN2[C@H]3O[C@H]4[C@@H](OP(OC4)([O-])=O)[C@H]3OC(CCC)=O)=O.[Na+] |
| EOS-AX9063 | KT 5720 | 108068-98-0 | C32H31N3O5 | 537.61 | CCCCCCOC([C@]([C@@]12C)(O)C[C@](O2)([H])N3C4=CC=CC=C4C5=C6C(CN=C6O)=C7C8=CC=CC=C8N1C7=C53)=O |
| EOS-AX9064 | cAMPS-Sp, triethylammonium salt | 73208-40-9 | C10H12N5O5PS.C6H15N | 446.46 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O4)([H])[C@@](O3)([H])CO[P@]4(O)=S)C2=NC=N1.CCN(CC)CC |
| EOS-AX9065 | cAMPS-Rp, triethylammonium salt | 151837-09-1 | C10 H12 N5 O5 P S . C6 H15 N | 446.46 | NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O4)([H])[C@@](O3)([H])CO[P@@]4(O)=S)C2=NC=N1.CCN(CC)CC |
| EOS-AX9066 | RHC 80267 | 83654-05-1 | C20H34N4O4 | 394.51 | O/C(O/N=C1CCCCC/1)=N\CCCCCC/N=C(O/N=C2CCCCC/2)\O |
| EOS-AX9067 | cGMP Dependent Kinase Inhibitor Peptide | 82801-73-8 | C38H74N18O10 | 943.12 | C[C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](N)([H])CCCNC(N)=N)([H])CCCCN)([H])CCCNC(N)=N)([H])/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=O)([H])CCC(O)=O)([H])CCCCN)([H])CCCNC(N)=N |
| EOS-AX9068 | c-JUN peptide | 610273-01-3 | C121 H210 N36 O34 S | 2743.55 | |
| EOS-AX9069 | SL 0101-1 | 77307-50-7 | C25H24O12 | 516.46 | C[C@@]1([H])[C@@](OC(C)=O)([H])[C@](OC(C)=O)([H])[C@](O)([H])[C@@](OC(C(C2=C(O)C=C(O)C=C2O3)=O)=C3C4=CC=C(O)C=C4)([H])O1 |
| EOS-AX9070 | PKI 14-22 amide, myristoylated | 201422-03-9 | C53H100N20O12 | 1209.5 | CCCCCCCCCCCCC/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](/C(O)=N/[C@@](C(O)=N)([H])[C@@](CC)([H])C)([H])C)([H])CC(O)=N)([H])CCCNC(N)=N)([H])CCCNC(N)=N)([H])[C@@](O)([H])C)([H])CCCNC(N)=N |
| EOS-AX9071 | AEG 3482 | 63735-71-7 | C10H8N4O2S2 | 280.33 | NS(C1=NN(C(S1)=N2)C=C2C3=CC=CC=C3)(=O)=O |
| EOS-AX9072 | BI 78D3 | 883065-90-5 | C13H9N5O5S2 | 379.37 | OC1=NN=C(SC2=NC=C(S2)N(=O)=O)N1C3=CC4=C(OCCO4)C=C3 |
| EOS-AX9073 | BRD 7389 | 376382-11-5 | C24H18N2O2 | 366.41 | O=C1C2=CC=CC=C2C3=C(NCCC4=CC=CC=C4)C(O)=NC5=CC=CC1=C53 |
| EOS-AX9074 | U 73343 | 142878-12-4 | C29H42N2O3 | 466.66 | C[C@]12CC[C@]3([H])C4=CC=C(OC)C=C4CC[C@@]3([H])[C@]1([H])CC[C@]2([H])NCCCCCCN5C(CCC5=O)=O |
| EOS-AX9075 | ML 141 | 71203-35-5 | C22H21N3O3S | 407.49 | COC1=CC=C(C2CC(C3=CC=CC=C3)=NN2C4=CC=C(S(N)(=O)=O)C=C4)C=C1 |
| EOS-AX9076 | IQ 3 | 312538-03-7 | C20H11N3O3 | 341.32 | O=C(O/N=C1C2=CC=CC=C2C3=NC4=CC=CC=C4N=C3\1)C5=CC=CO5 |
| EOS-AX9077 | | | | | |
| EOS-AX9078 | (±)-Talinolol | 57460-41-0 | C20H33N3O3 | 363.5 | O=C(NC1CCCCC1)NC2=CC=C(OCC(O)CNC(C)(C)C)C=C2 |
| EOS-AX9079 | Thyroid Hormone Receptor Antagonist (1-850) | 251310-57-3 | C21H20F3N5O4 | 463.4 | O=C(NNC(/C=C1CCN(C2=CC=C([N+]([O-])=O)C=C2)CC/1)=O)NC3=CC(C(F)(F)F)=CC=C3 |
| EOS-AX9080 | Oligomycin Complex | 1404-19-9 | | | O=C([C@H]([C@@H]([C@H](C([C@](C)([C@@H]([C@H](C/C=C/C=C/[C@]([H])(CC[C@@]1([C@@H]([C@]([H])(O2)[C@H]([C@@]3(O1)C(C[C@H]([C@]([H])(O3)C[C@H](C)O)C)=O)C)C)[H])CC)C)O)O)=O)C)O)C)[C@@H]([C@H]([C@@H](/C=C/C2=O)C)O)C.O=C([C@H]([C@@H]([C@H](C([C@](C)([C@@H]([C@H |
| EOS-AX9081 | | | | | |
| EOS-AX9082 | SB 218078 | 135897-06-2 | C24H15N3O3 | 393.4 | O=C(NC1=O)C2=C1C3=C4C5=C2C6=C(C=CC=C6)N5C7OC(CC7)N4C8=C3C=CC=C8 |
| EOS-AX9083 | KJ Pyr 9 | 581073-80-5 | C22H15N3O4 | 385.4 | NC(C(C=C1)=CC=C1C2=CC(C3=CC=CO3)=NC(C4=CC=C([N+]([O-])=O)C=C4)=C2)=O |
| EOS-AX9084 | Guvacoline (hydrobromide) | 17210-51-4 | C7H11NO2 • HBr | 222.1 | O=C(OC)C1=CCCNC1.Br |
| EOS-AX9085 | Erythromycin A enol ether | 33396-29-1 | C37H65NO12 | 715.9 | O=C1[C@@H]([C@H]([C@@H]([C@]([H])([C@]2(CC(C)=C([C@@H]([C@H]([C@@](C)([C@H](O1)CC)O)O)C)O2)C)O[C@]3([C@@H]([C@H](C[C@H](O3)C)N(C)C)O)[H])C)O[C@@]4(O[C@H]([C@@H]([C@@](C)(C4)OC)O)C)[H])C |
| EOS-AX9086 | L-Phenylephrine | 59-42-7 | C9H13NO2 | 167.2 | OC1=CC=CC([C@@H](O)CNC)=C1 |
| EOS-AX9087 | PPIase-Parvulin Inhibitor | 64005-90-9 | C22H18N2O8 | 438.4 | O=C1N(CC(OCC)=O)C(C2=CC=C(C3=C4C=CC1=C23)C(N(CC(OCC)=O)C4=O)=O)=O |
| EOS-AX9088 | MJN110 | 1438416-21-7 | C22H21Cl2N3O4 | 462.3 | ClC1=CC=C(C(C2=CC=C(Cl)C=C2)N3CCN(C(ON4C(CCC4=O)=O)=O)CC3)C=C1 |
| EOS-AX9089 | BW 245C | 72814-32-5 | C19H32N2O5 | 368.5 | O=C(N1[H])[C@H](CCCCCCC(O)=O)N(CCC(O)C2CCCCC2)C1=O |
| EOS-AX9090 | (R)-(+)-Atenolol | 56715-13-0 | C14H22N2O3 | 266.3 | NC(CC1=CC=C(OC[C@H](O)CNC(C)C)C=C1)=O |
| EOS-AX9091 | 1-Deoxygalactonojirimycin (hydrochloride) | 75172-81-5 | C6H13NO4 • HCl | 199.6 | O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)NC1.Cl |
| EOS-AX9092 | Niranthin | 50656-77-4 | C24H32O7 | 432.5 | COC1=CC(C[C@@H](COC)[C@H](COC)CC2=CC(OC)=C(OC)C=C2)=CC3=C1OCO3 |
| EOS-AX9093 | STK393606 | 355827-05-3 | C14H9BrN4S | 345.2 | BrC1=CNC2=NC(SCC3=CC=CC=C3C#N)=NC2=C1 |
| EOS-AX9094 | Acetyl Podocarpic Acid Anhydride | 344327-48-6 | C38H46O7 | 614.8 | CC(=O)Oc1ccc2CC[C@H]3[C@](C)(CCC[C@]3(C)c2c1)[C@@H](=O)O[C@H](=O)[C@@]1(C)CCC[C@]2(C)c3cc(ccc3CC[C@@H]12)OC(=O)C |
| EOS-AX9095 | β-Gal-NONOate | 357192-77-9 | C10H19N3O7 | 293.3 | |
| EOS-AX9096 | Colistin Methanesulfonate (sodium salt) | 8068-28-8 | C58H105N16O28S5 • 5Na | 1749.8 | CCC(CCCC/C([O-])=N/C(/C(O)=N/C(/C(O)=N/C(/C([O-])=N/C(/C([O-])=N/C(/C([O-])=N/C(/C(O)=N/C(/C(O)=N/C(/C([O-])=N/C(/C(O)=N\1)CCNCS(O)(=O)=O)CCNCS(O)(=O)=O)CC(C)C)CC(C)C)CCNCS(O)(=O)=O)CC/N=C(O)/C1C(O)C)CCNCS(O)(=O)=O)C(O)C)CCNCS(O)(=O)=O)C.[Na+].[Na+].[Na+] |
| EOS-AX9097 | Statil | 72702-95-5 | C17H12BrFN2O3 | 391.2 | BrC1=CC=C(CN2C(C(C=CC=C3)=C3C(CC(O)=O)=N2)=O)C(F)=C1 |
| EOS-AX9098 | Cefpodoxime (free acid) | 80210-62-4 | C15H17N5O6S2 | 427.5 | O=C(N1[C@]2([H])SCC(COC)=C1C(O)=O)[C@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O |
| EOS-AX9099 | 3-acetyl-11-keto-β-Boswellic Acid | 67416-61-9 | C32H48O5 | 512.7 | O=C1C=C2[C@](CC[C@]3(C)[C@@]2([H])[C@@H](C)[C@H](C)CC3)(C)[C@]4(C)CC[C@@]5([H])[C@@](C)(C(O)=O)[C@H](OC(C)=O)CC[C@]5(C)[C@]41[H] |
| EOS-AX9100 | ML-354 | 89159-60-4 | C16H14N2O3 | 282.3 | CN1C(CO)=C(C2=CC=CC=C2)C3=C1C=CC([N+]([O-])=O)=C3 |
| EOS-AX9101 | Narasin (sodium salt) | 58331-17-2 | C43H71O11 • Na | 787 | C[C@@H]1[C@@]([C@@H](C)[C@H](O)[C@H](C)C([C@@H]([C@]2([H])[C@@H](C)C[C@@H](C)[C@]3(O[C@@]4(CC[C@]([C@@]5([H])CC[C@@](CC)(O)[C@H](C)O5)(C)O4)[C@H](O)C=C3)O2)CC)=O)([H])O[C@]([C@@H](CC)C([O-])=O)([H])[C@@H](C)C1.[Na+] |
| EOS-AX9102 | Losartan Carboxylic Acid | 124750-92-1 | C22H21ClN6O2 | 436.9 | [H]N1N=NN=C1C2=CC=CC=C2C3=CC=C(CN4C(C(O)=O)=C(Cl)N=C4CCCC)C=C3 |
| EOS-AX9103 | Niguldipine (hydrochloride) | 119934-51-9 | C36H39N3O6 • HCl | 646.2 | O=C(C(C(C1=CC([N+]([O-])=O)=CC=C1)C(C(OC)=O)=C(C)N2)=C2C)OCCCN3CCC(C4=CC=CC=C4)(C5=CC=CC=C5)CC3.Cl |
| EOS-AX9104 | MRS1523 | 212329-37-8 | C23H29NO3S | 399.5 | CCCOC(C1=C(CCC)C(C(SCC)=O)=C(CC)N=C1C2=CC=CC=C2)=O |
| EOS-AX9105 | O-Methylviridicatin | 6152-57-4 | C16H13NO2 | 251.3 | O=C1NC2=C(C=CC=C2)C(C3=CC=CC=C3)=C1OC |
| EOS-AX9106 | AZD 5153 | 1869912-39-9 | C25H33N7O3 | 479.6 | COC1=NN=C2N1N=C(N3CCC(C4=CC=C(OCCN5[C@H](C)C(N(C)CC5)=O)C=C4)CC3)C=C2 |
| EOS-AX9107 | AD57 (hydrochloride) | | C22H20F3N7O • HCl | 491.9 | CC(C)N1C2=NC=NC(N)=C2C(C3=CC=C(NC(NC4=CC(C(F)(F)F)=CC=C4)=O)C=C3)=N1.Cl |
| EOS-AX9108 | HAMI3379 | 712313-35-4 | C34H45NO8 | 595.7 | O=C(NC1CCCC(C(O)=O)C1)C2=CC(C(O)=O)=CC=C2OCCCC(C=C3)=CC=C3OCCCCOC4CCCCC4 |
| EOS-AX9109 | N-Benzylacetamidine (hydrobromide) | 186545-76-6 | C9H12N2 · HBr | 229.1 | CC(NCC1=CC=CC=C1)=N.Br |
| EOS-AX9110 | Monoacetylphloroglucinol | 480-66-0 | C8H8O4 | 168.1 | OC1=C(C(C)=O)C(O)=CC(O)=C1 |
| EOS-AX9111 | Methylpiperidino pyrazole | 289726-02-9 | C29H31N3O3 | 469.6 | CC1=C(C2=CC=C(OCCN3CCCCC3)C=C2)N(C4=CC=C(O)C=C4)N=C1C5=CC=C(O)C=C5 |
| EOS-AX9112 | Polymyxin B (sulfate) | 1405-20-5 | C56H98N16O13 • H2SO4 | 1301.6 | O=C(C(NC(C(CCN)NC(CCCCC(C)CC)=O)=O)C(C)O)NC(CCN)C(NC(CCNC(C(NC(C(NC(C(CCN)N1)=O)CCN)=O)C(O)C)=O)C(NC(CCN)C(NC(CC2=CC=CC=C2)C(NC(CC(C)C)C1=O)=O)=O)=O)=O.O=S(O)(O)=O |
| EOS-AX9113 | 11-keto-β-Boswellic Acid | 17019-92-0 | C30H46O4 | 470.4 | O=C1C=C2[C@](CC[C@]3(C)C2[C@@H](C)[C@H](C)CC3)(C)[C@]4(C)CCC5[C@@](C)(C(O)=O)[C@H](O)CC[C@]5(C)C41 |
| EOS-AX9114 | N-Oxalylglycine | 5262-39-5 | C4H5NO5 | 147.1 | OC(C(NCC(O)=O)=O)=O |
| EOS-AX9115 | L-Acetylcarnitine (hydrochloride) | | C9H18NO4 • HCl | 240.7 | OC(C[C@@H](OC(C)=O)C[N+](C)(C)C)=O.Cl |
| EOS-AX9116 | INK1117 | 1268454-23-4 | C19H17N5O3 | 363.4 | NC1=NC2=CC(C(C=C3)=CN4C3=NC=C4C(N5CCOCC5)=O)=CC=C2O1 |
| EOS-AX9117 | Pargyline (hydrochloride) | 306-07-0 | C11H13N • HCl | 195.7 | CN(CC#C)CC1=CC=CC=C1.Cl |
| EOS-AX9118 | LY171883 | 88107-10-2 | C16H22N4O3 | 318.4 | CCCc1c(OCCCCc2nnn[nH]2)ccc(C(=O)C)c1O |
| EOS-AX9119 | SR 144528 | 192703-06-3 | C29H34ClN3O | 475.2 | C[C@]1(C2)[C@H](NC(C3=NN(CC4=CC=C(C)C=C4)C(C5=CC(C)=C(Cl)C=C5)=C3)=O)C(C)(C)[C@@H]2CC1 |
| EOS-AX9120 | Clenbuterol (hydrochloride) | 21898-19-1 | C12H18Cl2N2O • HCl | 313.7 | ClC1=CC(C(O)CNC(C)(C)C)=CC(Cl)=C1N.Cl |
| EOS-AX9121 | Flibanserin | 167933-07-5 | C20H21F3N4O | 390.4 | O=C1N(CCN2CCN(C3=CC(C(F)(F)F)=CC=C3)CC2)C4=CC=CC=C4N1 |
| EOS-AX9122 | R-7050 | 303997-35-5 | C16H8ClF3N4S | 380.8 | ClC1=CC(N2C3=NN=C2C(F)(F)F)=C(C=C1)N=C3SC4=CC=CC=C4 |
| EOS-AX9123 | Iberin | 505-44-2 | C5H9NOS2 | 163.3 | CS(CCCN=C=S)=O |
| EOS-AX9124 | P32/98 (hemifumarate) | 251572-86-8 | C9H18N2OS • 1/2C4H4O4 | 260.4 | O=C([C@@H](N)[C@@H](C)CC)N1CCSC1.OC(/C=C/C(O)=O)=O |
| EOS-AX9125 | Enniatin B | 917-13-5 | C33H57N3O9 | 639.8 | O=C(O[C@H](C(C)C)C(N([C@H](C(O[C@@H](C(N([C@H](C(O[C@@H]1C(C)C)=O)C(C)C)C)=O)C(C)C)=O)C(C)C)C)=O)[C@H](C(C)C)N(C)C1=O |
| EOS-AX9126 | Rhodamine 123 (chloride) | 62669-70-9 | C21H17N2O3 • Cl | 380.8 | NC1=CC2=[O+]C3=C(C(C4=CC=CC=C4C(OC)=O)=C2C=C1)C=CC(N)=C3.[Cl-] |
| EOS-AX9127 | 22(R)-hydroxy Cholesterol | 17954-98-2 | C27H46O2 | 402.7 | CC(C)CC[C@@H](O)[C@@H](C)C1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@@]21C |
| EOS-AX9128 | ISCK03 | 945526-43-2 | C19H21N3O2S | 355.5 | O=S(NC1=CC=C(N2C=NC=C2)C=C1)(C3=CC=C(C(C)(C)C)C=C3)=O |
| EOS-AX9129 | JW 74 | 863405-60-1 | C24H20N6O2S | 456.5 | CC(C=C1)=CC=C1C2=NOC(CSC3=NN=C(C4=CC=NC=C4)N3C5=CC=C(OC)C=C5)=N2 |
| EOS-AX9130 | Nosiheptide | 56377-79-8 | C51H43N13O12S6 | 1222.4 | OC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC([C@](NC(C4=CSC([C@](NC(C5=CSC(/C(NC([C@](NC(C6=CSC7=N6)=O)([H])[C@@H](O)C)=O)=C/C)=N5)=O)([H])C[C@H](O)C(OC8)=O)=N4)=O)([H])CSC(C9=C(C)C(C8=CC=C%10)=C%10N9)=O)=N3)C7=C1 |
| EOS-AX9131 | 1-Linoleoyl Glycerol | 2258-92-6 | C21H38O4 | 354.5 | |
| EOS-AX9132 | CBL0137 | 1197996-80-7 | C21H24N2O2 | 336.4 | CC(C1=CC=C2C(C(C=C(C(C)=O)C=C3)=C3N2CCNC(C)C)=C1)=O |
| EOS-AX9133 | A-54556A | 95398-45-1 | C38H50N6O8 | 718.9 | O=C([C@@H](NC(/C=C/C=C/C=C/C)=O)CC1=CC=CC=C1)N[C@@H](COC2=O)C(N3[C@H](C(N([C@@H](C)C(N[C@H](C(N4[C@H]2C[C@@H](C)C4)=O)C)=O)C)=O)CCC3)=O |
| EOS-AX9134 | | | | | |
| EOS-AX9135 | Amphomycin | 1402-82-0 | C58H91N13O20 | 1290.4 | O=C([C@@H]1N(CCCC1)C([C@@](NC([C@@H](NC(C/C=C\CCCCCC(CC)C)=O)CC(O)=O)=O)([C@H](NC([C@@H]2CCCN2C([C@@H](NC([C@@]([H])([C@H](N)C)N3)=O)C(C)C)=O)=O)C)[H])=O)N[C@@]([C@@H](C(O)=O)C)(C(N[C@H](C(NCC(N[C@@H](CC(O)=O)C(NCC3=O)=O)=O)=O)CC(O)=O)=O)[H] |
| EOS-AX9136 | RD162 | 915087-27-3 | C22H16F4N4O2S | 476.4 | S=C1N(C2=CC=C(C#N)C(C(F)(F)F)=C2)C(C3(CCC3)N1C4=CC(F)=C(C(NC)=O)C=C4)=O |
| EOS-AX9137 | Piperaquine | 4085-31-8 | C29H32Cl2N6 | 535.5 | ClC1=CC2=C(C=C1)C(N3CCN(CC3)CCCN4CCN(CC4)C5=C6C=CC(Cl)=CC6=NC=C5)=CC=N2 |
| EOS-AX9138 | CBL0137 (hydrochloride) | 1197397-89-9 | C21H24N2O2 • HCl | 372.9 | CC(C1=CC=C2C(C(C=C(C(C)=O)C=C3)=C3N2CCNC(C)C)=C1)=O.Cl |
| EOS-AX9139 | KT195 | 1402612-58-1 | C27H26N4O2 | 438.5 | O=C(N1N=NC(C2=CC=C(C3=CC=C(OC)C=C3)C=C2)=C1)N4C(C5=CC=CC=C5)CCCC4 |
| EOS-AX9140 | FTase Inhibitor II | 156707-43-6 | C15H21N3O4S2 | 371.5 | O=C(N[C@H](C(O)=O)CCSC)C1=CC=C(NC([C@@H](N)CS)=O)C=C1 |
| EOS-AX9141 | Lanicemine | 153322-05-5 | C13H14N2 | 198.3 | N[C@H](C1=CC=CC=C1)CC2=CC=CC=N2 |
| EOS-AX9142 | CPTH2 (hydrochloride) | | C14H14ClN3S • HCl | 328.3 | ClC(C=C1)=CC=C1C2=CSC(N/N=C3CCCC\3)=N2.Cl |
| EOS-AX9143 | Butyrolactone 3 | 778649-18-6 | C9H12O4 | 184.2 | O=C1C([C@@H](C(O)=O)[C@H](CCC)O1)=C |
| EOS-AX9144 | IDO-IN-1 | 914638-30-5 | C9H7BrFN5O2 | 316.1 | FC1=CC=C(/N=C(C2=NON=C2N)\NO)C=C1Br |
| EOS-AX9145 | CCT018159 | 171009-07-7 | C20H20N2O4 | 352.4 | CCc1cc(c(O)cc1O)c1n[nH]c(C)c1c1ccc2OCCOc2c1 |
| EOS-AX9146 | Oleandomycin | 3922-90-5 | C35H61NO12 | 687.9 | O=C1[C@@H]([C@H]([C@H]([C@H](OC([C@@H]([C@H]([C@@H]([C@H]([C@H](C[C@@]12CO2)C)O[C@]3([C@@H]([C@H](C[C@H](O3)C)N(C)C)O)[H])C)O[C@@]4(O[C@H]([C@@H]([C@H](C4)OC)O)C)[H])C)=O)C)C)O)C |
| EOS-AX9147 | BEC | 63107-40-4 | C5H12BNO4S | 193 | OB(O)CCSC[C@@H](C(O)=O)N |
| EOS-AX9148 | XAP044 | 196928-50-4 | C15H9IO4 | 380.1 | O=C1C2=CC=C(O)C=C2OC=C1OC3=CC=C(I)C=C3 |
| EOS-AX9149 | NNGH | 161314-17-6 | C13H20N2O5S | 316.4 | ONC(CN(S(C1=CC=C(OC)C=C1)(=O)=O)CC(C)C)=O |
| EOS-AX9150 | 2-HBA | 131359-24-5 | C17H14O3 | 266.3 | OC1=C(/C=C/C(/C=C/C2=CC=CC=C2O)=O)C=CC=C1 |
| EOS-AX9151 | 2-thio-PAF | 96801-55-7 | C26H54NO6PS | 539.8 | |
| EOS-AX9152 | Methicillin (sodium salt) | 132-92-3 | C17H19N2O6S • Na | 402.4 | O=C(N[C@@H]1C(N2[C@]1([H])SC(C)(C)[C@@H]2C([O-])=O)=O)C3=C(OC)C=CC=C3OC.[Na+] |
| EOS-AX9153 | AL 8810 isopropyl ester | 208114-93-6 | C27H37FO4 | 444.6 | CC(C)OC(CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@H](O)C2CC3=CC=CC=C3C2)[C@@H](F)C[C@@H]1O)=O |
| EOS-AX9154 | Safingol | 15639-50-6 | C18H39NO2 | 301.5 | OC[C@H](N)[C@@H](O)CCCCCCCCCCCCCCC |
| EOS-AX9155 | BIM5078 | 337506-43-1 | C14H10ClN3O4S | 351.8 | CC1=NC2=CC=CC=C2N1S(C3=C(Cl)C=CC([N+]([O-])=O)=C3)(=O)=O |
| EOS-AX9156 | ACS 67 | 1088434-86-9 | C32H38O5S3 | 598.8 | O[C@@H]1[C@H](C/C=C\CCCC(OC2=CC=C(C3=CC(SS3)=S)C=C2)=O)[C@@H](CC[C@@H](O)CCC4=CC=CC=C4)[C@H](O)C1 |
| EOS-AX9157 | Ubiquitin Isopeptidase Inhibitor I | 108477-18-5 | C19H14N2O7S | 414.4 | O=C(/C(CS(C/1)(=O)=O)=C\C2=CC=C([N+]([O-])=O)C=C2)C1=C/C3=CC=C([N+]([O-])=O)C=C3 |
| EOS-AX9158 | UCM05 | 1094451-90-7 | C24H16O10 | 464.4 | OC1=C(O)C(O)=CC(C(OC2=CC(C=CC=C3)=C3C(OC(C4=CC(O)=C(O)C(O)=C4)=O)=C2)=O)=C1 |
| EOS-AX9159 | Neutrophil Elastase Inhibitor | 1448314-31-5 | C16H11N3O | 261.3 | O=C(C1=CC=CC(C)=C1)N2C3=CC=CC=C3C(C#N)=N2 |
| EOS-AX9160 | IWP-3 | 687561-60-0 | C22H17FN4O2S3 | 484.6 | O=C(CSC(N1C2=CC=C(F)C=C2)=NC3=C(SCC3)C1=O)NC4=NC5=C(C=C(C)C=C5)S4 |
| EOS-AX9161 | 2-Guanidinoethylmercaptosuccinic Acid | 77482-44-1 | C7H13N3O4S | 235.3 | OC(C(CC(O)=O)SCCNC(N)=N)=O |
| EOS-AX9162 | Amino Tadalafil | 385769-84-6 | C21H18N4O4 | 390.4 | O=C1N(N)CC(N2[C@H](C3=CC=C(OCO4)C4=C3)C5=C(C6=CC=CC=C6N5)C[C@@]21[H])=O |
| EOS-AX9163 | PX 866 | 502632-66-8 | C29H35NO8 | 525.6 | O=C(/C1=C\N(CC=C)CC=C)O[C@H](COC)[C@@]2(C)C1=C(O)C(C3=C2[C@H](OC(C)=O)C[C@@]4(C)[C@@]3([H])CCC4=O)=O |
| EOS-AX9164 | Proxyphylline | 603-00-9 | C10H14N4O3 | 238.2 | CN(C(N1C)=O)C2=C(N(CC(O)C)C=N2)C1=O |
| EOS-AX9165 | E6 Berbamine | 114784-59-7 | C44H43N3O9 | 757.8 | COC1=C(C2=C(CCN([C@]2([H])CC3=CC=C(OC(C4=CC=C([N+]([O-])=O)C=C4)=O)C(OC5=CC=C(C[C@@]67[H])C=C5)=C3)C)C=C1OC)OC8=CC6=C(CCN7C)C=C8OC |
| EOS-AX9166 | 2-Trifluoromethyl-2'-methoxychalcone | 1309371-03-6 | C17H13F3O2 | 306.3 | COC1=C(C(/C=C/C2=CC=CC=C2C(F)(F)F)=O)C=CC=C1 |
| EOS-AX9167 | EGFR/ErbB2 Inhibitor | 179248-61-4 | C23H21N3O3 | 387.4 | COC1=C(OC)C=C(C(NC2=CC=C(OCC3=CC=CC=C3)C=C2)=NC=N4)C4=C1 |
| EOS-AX9168 | | | | | |
| EOS-AX9169 | MPI-0441138 | 827030-33-1 | C16H14ClN3O | 299.8 | ClC(N=C1N(C2=CC=C(OC)C=C2)C)=NC3=C1C=CC=C3 |
| EOS-AX9170 | 1,4-DPCA | 331830-20-7 | C13H8N2O3 | 240.2 | O=C1C2=C(C3=NC=CC=C3C=C2)N([H])C=C1C(O)=O |
| EOS-AX9171 | MI-2 (hydrochloride) | | C18H25N5S2 • 2HCl | 448.5 | CCCC(S1)=CC(C1=NC=N2)=C2N3CCN(C4=NCC(C)(C)S4)CC3.Cl.Cl |
| EOS-AX9172 | EGFR Inhibitor | 879127-07-8 | C21H18F3N5O | 413.4 | O=C(C1CC1)NC2=CC=CC(NC3=CC(NC4=CC(C(F)(F)F)=CC=C4)=NC=N3)=C2 |
| EOS-AX9173 | DL-α-Difluoromethylornithine (hydrochloride hydrate) | 96020-91-6 | C6H12F2N2O2 • HCl [H2O] | 236.6 | FC(F)C(C(O)=O)(N)CCCN.Cl.O |
| EOS-AX9174 | Actinonin | 13434-13-4 | C19H35N3O5 | 385.5 | O=C([C@H](C(C)C)NC([C@H](CCCCC)CC(NO)=O)=O)N1CCC[C@H]1CO |
| EOS-AX9175 | (S)-Ketoprofen | 22161-81-5 | C16H14O3 | 254.3 | O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2 |
| EOS-AX9176 | 3MB-PP1 | 956025-83-5 | C17H21N5 | 295.4 | NC1=C(C(CC2=CC=CC(C)=C2)=NN3C(C)(C)C)C3=NC=N1 |
| EOS-AX9177 | MAZ51 | 163655-37-6 | C21H18N2O | 314.4 | CN(C)C1=C(C=CC=C2)C2=C(/C=C3C(NC4=C/3C=CC=C4)=O)C=C1 |
| EOS-AX9178 | Tetradecyl Phosphonate | 4671-75-4 | C14H31O3P | 278.4 | CCCCCCCCCCCCCCP(=O)(O)O |
| EOS-AX9179 | Clinafloxacin (hydrochloride) | 105956-99-8 | C17H17ClFN3O3 • HCl | 402.3 | OC(C1=CN(C2CC2)C3=C(Cl)C(N4CCC(N)C4)=C(F)C=C3C1=O)=O.Cl |
| EOS-AX9180 | Isoxsuprine (hydrochloride) | 579-56-6 | C18H23NO3 • HCl | 337.8 | OC1=CC=C(C(O)C(C)NC(C)COC2=CC=CC=C2)C=C1.Cl |
| EOS-AX9181 | R-1 Methanandamide Phosphate | 649569-33-5 | C23H40NO5P | 441.5 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(N([H])[C@H](C)COP(O)(O)=O)=O |
| EOS-AX9182 | α-Naphthoflavone | 604-59-1 | C19H12O2 | 272.3 | O=C1C2=C(C(C=CC=C3)=C3C=C2)OC(C4=CC=CC=C4)=C1 |
| EOS-AX9183 | ML-356 | 1808260-45-8 | C19H25N3O4S2 | 423.5 | O=S(C1=CC=C(C2=CSC(NC(C(CC)CC)=O)=N2)C=C1)(N3CCOCC3)=O |
| EOS-AX9184 | RS-1 | 312756-74-4 | C20H16Br2N2O3S | 524.2 | BrC1=CC=C(NC(C2=CC=C(Br)C(S(NCC3=CC=CC=C3)(=O)=O)=C2)=O)C=C1 |
| EOS-AX9185 | ABH | 222638-65-5 | C6H14BNO4 | 175 | OB(O)CCCC[C@@H](C(O)=O)N |
| EOS-AX9186 | 7-hydroxycoumarinyl Arachidonate | 161180-11-6 | C29H36O4 | 448.6 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)Oc1ccc2ccc(=O)oc2c1 |
| EOS-AX9187 | Bleomycin A5 (hydrochloride) | 55658-47-4 | C57H89N19O21S2 • XHCl | 1477 | CC(C(N1)=N)=C(N=C1[C@](NC[C@@](N)([H])C(O)=N)([H])CC(O)=N)/C(O)=N/[C@@](/C(O)=N/[C@]([C@](O)([H])[C@@](/C(O)=N/[C@@](/C(O)=N/CCC2=NC(C3=NC(/C(O)=N/CCCNCCCCN)=CS3)=CS2)([H])[C@@](O)([H])C)([H])C)([H])C)([H])[C@](O[C@@]4([H])[C@](O[C@]5([H])[C@](O)([H])[C@] |
| EOS-AX9188 | MI-nc (hydrochloride) | 1934302-23-4 | C14H16N6S2 • 2HCl | 405.4 | CCC(S1)=CC(C1=NC=N2)=C2N3CCN(C4=NN=CS4)CC3.Cl.Cl |
| EOS-AX9189 | Hydroxytacrine (maleate) | 118909-22-1 | C13H14N2O • C4H4O4 | 330.3 | NC1=C2C(CCCC2O)=NC3=CC=CC=C31.OC(/C=C\C(O)=O)=O |
| EOS-AX9190 | 13Z,16Z-Docosadienoic Acid | 17735-98-7 | C22H40O2 | 336.6 | CCCCC/C=C\C/C=C\CCCCCCCCCCCC(O)=O |
| EOS-AX9191 | HJC0197 | 1383539-73-8 | C19H21N3OS | 339.5 | CC(C=CC(C)=C1)=C1CSC(NC(C2CCCC2)=C3C#N)=NC3=O |
| EOS-AX9192 | PPACKII (trifluoroacetate salt) | 649748-23-2 | C25H33ClN6O3 • 2CF3COOH | 729.1 | O=C([C@@H](CC1=CC=CC=C1)N)N[C@@H](CC2=CC=CC=C2)C(N[C@H](C(CCl)=O)CCCNC(N)=N)=O.FC(F)(C(O)=O)F.FC(F)(C(O)=O)F |
| EOS-AX9193 | CBFβ Inhibitor | 493028-20-9 | C12H14N2OS | 234.3 | COC1=CC=C(C2=C(CC)SC(N)=N2)C=C1 |
| EOS-AX9194 | α-Zearalenol | 36455-72-8 | C18H24O5 | 320.4 | OC1=C(C(O[C@@H](C)CCC[C@H](O)CCC/C=C/2)=O)C2=CC(O)=C1 |
| EOS-AX9195 | L-Homopropargyl Glycine | 98891-36-2 | C6H9NO2 | 127.1 | C#CCC[C@H](N)C(O)=O |
| EOS-AX9196 | GQ-16 | 870554-67-9 | C19H16BrNO3S | 418.3 | BrC1=CC(/C=C2C(N(CC3=CC=C(C)C=C3)C(S/2)=O)=O)=C(OC)C=C1 |
| EOS-AX9197 | Oligomycin C | 11052-72-5 | C45H74O10 | 775.1 | O=C([C@@H](C)[C@H](O)[C@@H](C)/C=C/1)[C@H](C)[C@@H](O)[C@H](C)C([C@@H](C)[C@@H](O)[C@H](C)C/C=C/C=C/[C@@](CC)([H])CC[C@@]2([H])[C@@H](C)[C@@]([C@H](C)[C@@]3(CC[C@H](C)[C@@](C[C@H](O)C)([H])O3)O2)([H])OC1=O)=O |
| EOS-AX9198 | 3-chloro-5-hydroxy BA | 53984-36-4 | C7H5ClO3 | 172.6 | ClC1=CC(O)=CC(C(O)=O)=C1 |
| EOS-AX9199 | (S)-Mephenytoin | 70989-04-7 | C12H14N2O2 | 218.3 | O=C1[C@@](C2=CC=CC=C2)(CC)NC(N1C)=O |
| EOS-AX9200 | Tivozanib (hydrate) | 682745-40-0 | C22H19ClN4O5 • H2O | 472.9 | COC1=C(OC)C=C(C(OC2=CC(Cl)=C(NC(NC3=NOC(C)=C3)=O)C=C2)=CC=N4)C4=C1.O |
| EOS-AX9201 | Oxiconazole (nitrate) | 64211-46-7 | C18H13Cl4N3O • HNO3 | 492.1 | ClC1=CC(Cl)=C(/C(CN2C=NC=C2)=N/OCC3=C(Cl)C=C(Cl)C=C3)C=C1.[O-][N+](O)=O |
| EOS-AX9202 | Cannabidiol dimethyl ether | 1242-67-7 | C23H34O2 | 342.5 | CCCCCc1cc(OC)c(c(OC)c1)[C@@H]1C=C(C)CCC1C(=C)C |
| EOS-AX9203 | Ginkgolic Acid C15:1 | 22910-60-7 | C22H34O3 | 346.5 | OC1=CC=CC(CCCCCCC/C=C\CCCCCC)=C1C(O)=O |
| EOS-AX9204 | Polyinosinic-polycytidylic Acid (potassium salt) | 31852-29-6 | (C10 H13 N4 O8 P)x • (C9 H14 N3 O8 P)x • XK | | O=C1[N]2=C(N[H]/O=C3C(N=CN4[C@@H]5O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]5O)=C4N=CN/3[H]2)C=CN1[C@@H]6O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]6O.[K] |
| EOS-AX9205 | Penicillic Acid | 90-65-3 | C8H10O4 | 170.2 | C=C(C)C(/C(OC)=C\C(O)=O)=O |
| EOS-AX9206 | Ertapenem (sodium salt) | 153832-38-3 | C22H23N3O7S • 2Na | 519.5 | O=C1[C@@]([C@@H](C)O)([H])[C@]2([H])N1C(C([O-])=O)=C(S[C@@H]3CN[C@H](C(NC4=CC(C([O-])=O)=CC=C4)=O)C3)[C@@H]2C.[Na+].[Na+] |
| EOS-AX9207 | Sulindac sulfone | 59864-04-9 | C20H17FO4S | 372.4 | FC1=CC=C(/C(C(C)=C2CC(O)=O)=C/C3=CC=C(S(C)(=O)=O)C=C3)C2=C1 |
| EOS-AX9208 | Dinactin | 20261-85-2 | C42H68O12 | 765 | O=C(O[C@H](CC)C[C@]1([H])O[C@@]([C@@H]2C)([H])CC1)[C@H](C)[C@@]3([H])CC[C@](C[C@H](C)OC([C@H]([C@@]4([H])O[C@](C[C@H](OC([C@H](C)[C@]5([H])O[C@](CC5)([H])C[C@H](C)OC2=O)=O)CC)([H])CC4)C)=O)([H])O3 |
| EOS-AX9209 | | | | | |
| EOS-AX9210 | Kanosamine (hydrochloride) | 57649-10-2 | C6H13NO5 • HCl | 215.6 | O=C([H])[C@H](O)[C@@H](N)[C@H](O)[C@H](O)CO.Cl |
| EOS-AX9211 | BCATc Inhibitor 2 | 406191-34-2 | C16H10ClF3N2O4S | 418.8 | ClC1=CC=C2C(C=C(C(NNS(C3=C(C(F)(F)F)C=CC=C3)(=O)=O)=O)O2)=C1 |
| EOS-AX9212 | Omeprazole sulfone | 88546-55-8 | C17H19N3O4S | 361.4 | COC1=CC=C2C(N=C(S(CC3=C(C)C(OC)=C(C)C=N3)(=O)=O)N2)=C1 |
| EOS-AX9213 | ML-264 | 1550008-55-3 | C17H21ClN2O4S | 384.9 | ClC1=CC=CC(/C=C/C(NCC(N(C)C2CCS(CC2)(=O)=O)=O)=O)=C1 |
| EOS-AX9214 | PF-9184 | 1221971-47-6 | C21H14Cl2N2O4S | 461.3 | OC1=C(C(NC2=CC=C(C3=CC=C(Cl)C(Cl)=C3)C=C2)=O)NS(C4=CC=CC=C41)(=O)=O |
| EOS-AX9215 | Zoniporide (hydrochloride) | 241800-97-5 | C17H16N6O • HCl | 393.3 | O=C(C(C=N1)=C(C2CC2)N1C3=C4C(N=CC=C4)=CC=C3)/N=C(N)/N.Cl |
| EOS-AX9216 | SR 1555 (hydrochloride) | | C22H22F6N2O2 • HCl | 496.9 | O=C(C)N(CC1)CCN1CC2=CC=C(C3=CC=C(C(O)(C(F)(F)F)C(F)(F)F)C=C3)C=C2.Cl |
| EOS-AX9217 | Thymidine | 50-89-5 | C10H14N2O5 | 242.2 | CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)C2)C(NC1=O)=O |
| EOS-AX9218 | ML-60218 | 577784-91-9 | C19H15Cl2N3O2S2 | 452.4 | ClC1=CC2=C(SC(C3=NN(C)C(NS(C4=C(Cl)C=CC=C4)(=O)=O)=C3)=C2C)C=C1 |
| EOS-AX9219 | Ramiprilat | 87269-97-4 | C21H28N2O5 | 388.5 | O=C([C@H](C)N[C@H](C(O)=O)CCC1=CC=CC=C1)N2[C@]3([H])[C@](CCC3)([H])C[C@H]2C(O)=O |
| EOS-AX9220 | AM4113 | 614726-85-1 | C17H12Cl3N3O | 380.7 | ClC1=CC(Cl)=CC=C1N2C(C3=CC=C(Cl)C=C3)=C(C)C(C(N)=O)=N2 |
| EOS-AX9221 | Oligomycin B | 11050-94-5 | C45H72O12 | 805.1 | O=C([C@H](C)[C@@H](O)[C@H](C)/C=C/1)[C@@H](C)[C@H](O)[C@@H](C)C([C@](O)(C)[C@H](O)[C@@H](C)C/C=C/C=C/[C@](CC)([H])CC[C@]2([H])[C@H](C)[C@]([C@@H](C)[C@]3(C(C[C@@H](C)[C@](C[C@@H](O)C)([H])O3)=O)O2)([H])OC1=O)=O |
| EOS-AX9222 | DBIBB | 1569309-92-7 | C23H20N2O6S | 452.5 | O=C(C1=C2C(C=CC=C23)=CC=C1)N(CCCCNS(C4=C(C(O)=O)C=CC=C4)(=O)=O)C3=O |
| EOS-AX9223 | Enniatin Complex | 11113-62-5 | C33H57N3O9 (for B) | 639.8 | O=C(O[C@H](C(C)C)C(N([C@H](C(O[C@@H](C(N([C@H](C(O[C@@H]1C(C)C)=O)C(C)C)C)=O)C(C)C)=O)C(C)C)C)=O)[C@H](C(C)C)N(C)C1=O.O=C(O[C@H](C(C)C)C(N([C@H](C(O[C@@H](C(N([C@H](C(O[C@@H]2C(C)C)=O)[C@@H](CC)C)C)=O)C(C)C)=O)[C@H](C)CC)C)=O)[C@H]([C@@H](CC)C)N(C)C2 |
| EOS-AX9224 | MS023 (hydrochloride) | | C17H25N3O • 3HCl | 396.8 | CC(C)OC1=CC=C(C2=CNC=C2CN(C)CCN)C=C1.Cl.Cl.Cl |
| EOS-AX9225 | 5-(N,N-dimethyl)-Amiloride (hydrochloride) | 2235-97-4 | C8H12ClN7O • HCl | 294.1 | CN(C)C1=NC(N)=C(C(NC(N)=N)=O)N=C1Cl.Cl |
| EOS-AX9226 | Piperlonguminine | 5950-12-9 | C16H19NO3 | 273.3 | O=C(/C=C/C=C/C1=CC=C(OCO2)C2=C1)NCC(C)C |
| EOS-AX9227 | Chlorprothixene (hydrochloride) | 6469-93-8 | C18H18ClNS • HCl | 352.3 | ClC1=CC2=C(C=C1)SC3=CC=CC=C3/C2=C/CCN(C)C.Cl |
| EOS-AX9228 | MBCQ | 150450-53-6 | C16H12ClN3O2 | 313.7 | ClC1=CC2=C(C=C1)N=CN=C2NCC3=CC(OCO4)=C4C=C3 |
| EOS-AX9229 | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | 1314230-75-5 | C30H36N2O4 | 488.6 | O=C(C1=CN(CCCCC)C2=C(C=C(C3=CC=CO3)C=C2OC)C1=O)N[C@@]45CC6C[C@H](C5)C[C@H](C4)C6 |
| EOS-AX9230 | KT182 | 1402612-62-7 | C27H26N4O2 | 438.5 | O=C(N1N=NC(C2=CC=C(C3=CC=CC(CO)=C3)C=C2)=C1)N4C(C5=CC=CC=C5)CCCC4 |
| EOS-AX9231 | KT203 | 1402612-64-9 | C28H26N4O3 | 466.5 | O=C(N1N=NC(C2=CC=C(C3=CC=CC(C(O)=O)=C3)C=C2)=C1)N4C(CC5=CC=CC=C5)CCCC4 |
| EOS-AX9232 | Arylquin 1 | 1630743-73-5 | C17H16FN3 | 281.3 | CN(C)C1=CC=C2C(N=C(N)C(C3=CC=CC=C3F)=C2)=C1 |
| EOS-AX9233 | Hispidin | 555-55-5 | C13H10O5 | 0 | OC1=CC(/C=C/C(O2)=CC(O)=CC2=O)=CC=C1O |
| EOS-AX9234 | diacetoxy Scirpenol | 2270-40-8 | C19H26O7 | 366.4 | CC1=C[C@]2([H])[C@]([C@]([C@H](OC(C)=O)[C@H]3O)(C)[C@@]4(OC4)[C@]3([H])O2)(COC(C)=O)CC1 |
| EOS-AX9235 | Lagosin | 6834-98-6 | C35H58O12 | 670.8 | C/C1=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC([C@@]([C@H](O)CCCCC)([H])[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@@H]1O)=O |
| EOS-AX9236 | Citrinin | 518-75-2 | C13H14O5 | 250.3 | O=C1C(C)=C2[C@@H](C)[C@H](C)OC=C2C(O)=C1C(O)=O |
| EOS-AX9237 | Nisin A | 1414-45-5 | C143H230N42O37S7 | 3354.1 | O=C(N1[C@@]([H])(CCC1)C(NC2)=O)[C@@H](NC([C@@H](NC([C@H](CC(C)C)NC(C(N3)=C)=O)=O)CSC[C@@H](NC(/C(NC([C@H]([C@H](CC)C)N)=O)=C/C)=O)C(N[C@]([H])(C3=O)[C@H](CC)C)=O)=O)[C@H](C)SC[C@@H](C(N[C@H](C(N[C@@H]([C@H](C)SC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C |
| EOS-AX9238 | Piericidin A | 2738-64-9 | C25H37NO4 | 415.6 | COC1=C(O)C(C)=C(C/C=C(C)/C/C=C/C(C)=C/[C@H]([C@@H](O)/C(C)=C/C)C)N=C1OC |
| EOS-AX9239 | Losartan Carboxaldehyde | 114798-36-6 | C22H21ClN6O | 420.9 | [H]N1N=NN=C1C2=CC=CC=C2C3=CC=C(CN4C(C([H])=O)=C(Cl)N=C4CCCC)C=C3 |
| EOS-AX9240 | Cefamandole (sodium salt) | 30034-03-8 | C18H17N6O5S2 • Na | 484.5 | O=C(N[C@@H]1C(N2[C@]1([H])SCC(CSC3=NN=NN3C)=C2C([O-])=O)=O)[C@H](O)C4=CC=CC=C4.[Na+] |
| EOS-AX9241 | BMS 687453 | 1000998-59-3 | C22H21ClN2O6 | 444.9 | OC(CN(C(OC)=O)CC1=CC(OCC2=C(C)OC(C3=CC=C(Cl)C=C3)=N2)=CC=C1)=O |
| EOS-AX9242 | HE-3235 | 183387-50-0 | C21H32O2 | 316.5 | C[C@@]12[C@](CC[C@]2(C#C)O)([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC1 |
| EOS-AX9243 | Oxipurinol | 2465-59-0 | C5H4N4O2 | 152.1 | O=C1C2=C(NN=C2)NC(N1)=O |
| EOS-AX9244 | Fructose 1,6-bisphosphatase-1 Inhibitor | 883973-99-7 | C13H7Cl3N2O3S | 377.6 | ClC1=CC=C2C(N=C(NS(C3=C(Cl)C=CC(Cl)=C3)(=O)=O)O2)=C1 |
| EOS-AX9245 | StemRegenin 1 (hydrochloride) | | C24H23N5OS • HCl | 466 | OC1=CC=C(C=C1)CCNC2=C3C(N(C(C)C)C=N3)=NC(C4=CSC5=C4C=CC=C5)=N2.Cl |
| EOS-AX9246 | 4'-bromo-Resveratrol | 1224713-90-9 | C14H11BrO2 | 291.1 | OC1=CC(O)=CC(/C=C/C2=CC=C(Br)C=C2)=C1 |
| EOS-AX9247 | 2-Iminobiotin | 13395-35-2 | C10H17N3O2S | 243.3 | [H][C@](NC1=N)(CS[C@H]2CCCCC(O)=O)[C@@]2(N1)[H] |
| EOS-AX9248 | 4-Methylbenzylidene camphor | 36861-47-9 | C18H22O | 254.4 | CC1=CC=C(/C=C2[C@H]3CC[C@@](C)(C3(C)C)C/2=O)C=C1 |
| EOS-AX9249 | NF-κB Activation Inhibitor III | 380623-76-7 | C10H5ClN4O5S | 328.7 | ClC1=C([N+]([O-])=O)C=CC(C(NC2=NC=C([N+]([O-])=O)S2)=O)=C1 |
| EOS-AX9250 | SKF 525A (hydrochloride) | 62-68-0 | C23H31NO2 • HCl | 390 | O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(CCC)C2=CC=CC=C2.Cl |
| EOS-AX9251 | SB 290157 (trifluoroacetate salt) | 1140525-25-2 | C22H28N4O4 • CF3COOH | 526.5 | O=C(N[C@H](C(O)=O)CCCNC(N)=N)COCC(C1=CC=CC=C1)C2=CC=CC=C2.FC(F)(C(O)=O)F |
| EOS-AX9252 | 2,3-Butanedione-2-monoxime | 57-71-6 | C4H7NO2 | 101.1 | CC(/C(C)=N/O)=O |
| EOS-AX9253 | (S)-SLV 319 | 464213-10-3 | C23H20Cl2N4O2S | 487.4 | C/N=C(\NS(=O)(=O)c1ccc(Cl)cc1)/N1N=C(c2ccc(Cl)cc2)C(C1)c1ccccc1 |
| EOS-AX9254 | SW203668 | 1673556-40-5 | C22H19N3O2S | 389.5 | COC1=CC=C2C(SC(NC(C3=CC=C(C(N)C4=CC=CC=C4)C=C3)=O)=N2)=C1 |
| EOS-AX9255 | JD5037 | 1392116-14-1 | C27H27Cl2N5O3S | 572.5 | ClC(C=C1)=CC=C1C2=NN(/C(N[C@@H](C(C)C)C(N)=O)=N/S(C3=CC=C(Cl)C=C3)(=O)=O)C[C@@H]2C4=CC=CC=C4 |
| EOS-AX9256 | 4-Quinolone-3-Carboxamide CB2 Ligand | 1314230-69-7 | C26H34N2O3 | 422.6 | O=C(C1=CN(CCCCC)C2=C(C=CC=C2OC)C1=O)N[C@@]34CC5C[C@H](C4)C[C@H](C3)C5 |
| EOS-AX9257 | ARN14974 | 1644158-57-5 | C24H21FN2O3 | 404.4 | FC(C=C1)=CC=C1C2=CC=C3C(OC(N3C(NCCCCC4=CC=CC=C4)=O)=O)=C2 |
| EOS-AX9258 | ZINC12613047 | 1069521-64-7 | C29H34N2O2 | 442.6 | COCCN(C(C1=CC(C=CC=C2)=C2C=C1)=O)CC3CCCN(C4CC(C=CC=C5)=C5C4)C3 |
| EOS-AX9259 | ML-336 | 1613465-33-0 | C19H21N5O3 | 367.4 | CN1CCN(C)C/C1=N\C2=C(C(NC3=CC=CC=C3)=O)C=C([N+]([O-])=O)C=C2 |
| EOS-AX9260 | PBIT | 2514-30-9 | C14H11NOS | 241.3 | O=C1C2=CC=CC=C2SN1C3=CC=C(C)C=C3 |
| EOS-AX9261 | PTP Inhibitor II | 2632-13-5 | C9H9BrO2 | 229.1 | COC1=CC=C(C(CBr)=O)C=C1 |
| EOS-AX9262 | Spinosyn A | 131929-60-7 | C41H65NO10 | 732 | CN(C)[C@H]1CC[C@@](O[C@H]([C@@H](C)C2=O)CCC[C@H](CC)OC(C[C@]3([H])C2=C[C@]4([H])[C@@]3([H])C=C[C@@]5([H])[C@@]4([H])C[C@H](O[C@]6([H])O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]6OC)C5)=O)([H])O[C@@H]1C |
| EOS-AX9263 | Guanylyl Imidodiphosphate | 148892-91-5 | C10H14N6O13P3 • 3Na | 588.1 | O[C@H]1[C@H](N2C=NC3=C2N=C(N)NC3=O)O[C@H](COP(OP(NP(O)([O-])=O)([O-])=O)([O-])=O)[C@H]1O.[Na+].[Na+].[Na+] |
| EOS-AX9264 | CPHPC | 224624-80-0 | C16H24N2O6 | 340.4 | O=C(CCCCC(N1CCC[C@@H]1C(O)=O)=O)N2[C@@H](C(O)=O)CCC2 |
| EOS-AX9265 | Polymyxin B1 | 4135-11-9 | C56H98N16O13 | 1203.5 | O=C([C@@H](NC([C@H](CCN)NC(CCCC[C@@H](C)CC)=O)=O)[C@@H](C)O)N[C@@H](CCN)C(N[C@@H](CCNC([C@@H](NC([C@@H](NC([C@H](CCN)N1)=O)CCN)=O)[C@H](O)C)=O)C(N[C@@H](CCN)C(N[C@H](CC2=CC=CC=C2)C(N[C@@H](CC(C)C)C1=O)=O)=O)=O)=O |
| EOS-AX9266 | Nullscript | 300816-11-9 | C16H14N2O4 | 298.3 | O=C(C1=CC=CC2=CC=CC3=C12)N(CCCC(NO)=O)C3=O |
| EOS-AX9267 | PTP Inhibitor I | 2491-38-5 | C8H7BrO2 | 215 | OC1=CC=C(C(CBr)=O)C=C1 |
| EOS-AX9268 | (Z-Ala-Ala-Ala-Ala)2Rh110 | 149695-85-2 | C60H66N10O15 | 1167.2 | O=C(O1)C2=CC=CC=C2C31C4=C(C=C(NC(C(C)NC(C(C)NC(C(C)NC(C(C)NC(OCC5=CC=CC=C5)=O)=O)=O)=O)=O)C=C4)OC6=C3C=CC(NC(C(C)NC(C(C)NC(C(C)NC(C(C)NC(OCC7=CC=CC=C7)=O)=O)=O)=O)=O)=C6 |
| EOS-AX9269 | Hypophyllanthin | 33676-00-5 | C24H30O7 | 430.5 | COC[C@@H]1[C@@H](COC)CC(C=C(OC)C2=C3OCO2)=C3[C@H]1C4=CC(OC)=C(OC)C=C4 |
| EOS-AX9270 | Ethyl 3-Aminobenzoate (methanesulfonate) | 886-86-2 | C9H11NO2 • CH4O3S | 261.3 | O=C(OCC)C1=CC(N)=CC=C1.O=S(O)(C)=O |
| EOS-AX9271 | CUDA | 479413-68-8 | C19H36N2O3 | 340.5 | O=C(NCCCCCCCCCCCC(O)=O)NC1CCCCC1 |
| EOS-AX9272 | TNP-470 | 129298-91-5 | C19H28ClNO6 | 401.9 | O=C(NC(CCl)=O)O[C@@H]1CC[C@@]2(OC2)[C@]([C@](O3)(C)[C@H]3C/C=C(C)/C)([H])[C@@H]1OC |
| EOS-AX9273 | IWP-2-V2 | 877618-79-6 | C23H20N4O2S | 480.6 | O=C(CSC(N1CC2=CC=CC=C2)=NC3=C(SCC3)C1=O)NC4=NC5=C(C=C(C)C=C5)S4 |
| EOS-AX9274 | L-NIO (hydrochloride) | 36889-13-1 | C7H15N3O2 • 2HCl | 246.1 | CC(=N)NCCC[C@H](N)C(=O)O |
| EOS-AX9275 | Lysine-specific Demethylase Inhibitor (1C) | 927019-63-4 | C15H36N8 | 328.5 | CN/C(NCCCNCCCNCCCN/C(NC)=N/C)=N\C |
| EOS-AX9276 | O-1821 | 35482-50-9 | C17H22O2 | 258.4 | CC1=C[C@@H](C2=C(O)C=C(C)C=C2O)[C@H](C(C)=C)CC1 |
| EOS-AX9277 | Zilpaterol | 119520-05-7 | C14H19N3O2 | 261.3 | O=C1NC2=CC=CC3=C2N1CC[C@H](NC(C)C)[C@H]3O |
| EOS-AX9278 | Apelin-13 | 217082-58-1 | C69H111N23O16S | 1550.8 | O=C([C@H](CCSC)NC(C1N(C(CNC([C@H](CCCCN)NC([C@@H](NC([C@H](CO)NC([C@H](CC(C)C)NC([C@H](CCCNC(N)=N)NC([C@H]2N(C([C@@H](NC([C@@H](N)CCC(N)=O)=O)CCCNC(N)=N)=O)CCC2)=O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)CCC1)=O)N4[C@H](C(N[C@H](C(O)=O)CC5=CC=CC=C5)=O)CCC4 |
| EOS-AX9279 | BAY 41-8543 | 256498-66-5 | C21H21FN8O | 420.4 | FC(C=CC=C1)=C1CN2N=C(C3=NC(N)=C(N4CCOCC4)C(N)=N3)C5=C2N=CC=C5 |
| EOS-AX9280 | CJ-023423 | 415903-37-6 | C26H29N5O3S | 491.6 | O=C(NS(C1=CC=C(C)C=C1)(=O)=O)NCCC2=CC=C(N3C(CC)=NC4=C(C)N=C(C)C=C43)C=C2 |
| EOS-AX9281 | LH 21 | 611207-11-5 | C20H20Cl3N3 | 407.1 | CCCCCCC1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(Cl)C=C3)=N1 |
| EOS-AX9282 | Danazol | 17230-88-5 | C22H27NO2 | 337.5 | O[C@@]1(C#C)CC[C@@]2([H])[C@]3([H])CCC4=CC5=C(C=NO5)C[C@]4(C)[C@@]3([H])CC[C@@]21C |
| EOS-AX9283 | ML-211 | | C25H30N4O2 | 418.5 | CC(C)(C)C1CCN(C(N2N=C(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)C=N2)=O)CC1 |
| EOS-AX9284 | Stachydrine (hydrochloride) | | C7H13NO2 • HCl | 179.6 | C[N+]1(C)CCC[C@H]1C([O-])=O.Cl |
| EOS-AX9285 | Ceranib-2 | 1402830-75-4 | C25H19NO3 | 381.4 | O=C(N1)C(C(/C=C/C2=CC=C(OC)C=C2)=O)=C(C3=CC=CC=C3)C4=C1C=CC=C4 |
| EOS-AX9286 | ALK5 Inhibitor II (hydrochloride) | | C17H13N5 • HCl | 323.8 | CC1=NC(C2=NNC=C2C3=NC4=CC=CN=C4C=C3)=CC=C1.Cl |
| EOS-AX9287 | WWL123 | 1338575-41-9 | C28H24N2O3 | 436.5 | O=C(N)C1=CC=C(C2=CC(OC(N(C)CC3=CC=CC(C4=CC=CC=C4)=C3)=O)=CC=C2)C=C1 |
| EOS-AX9288 | GSK6853 | 1910124-24-1 | C22H27N5O3 | 409.5 | C[C@H](CNCC1)N1C2=C(NC(C3=CC=CC=C3OC)=O)C=C4C(N(C)C(N4C)=O)=C2 |
| EOS-AX9289 | 4,5,6,7-Tetrabromobenzimidazole | 577779-57-8 | C7H2Br4N2 | 433.7 | BrC1=C2C(N=CN2)=C(Br)C(Br)=C1Br |
| EOS-AX9290 | PD 166326 | 185039-91-2 | C21H16Cl2N4O2 | 427.3 | OCC1=CC=CC(NC2=NC(N(C)C(C(C3=C(Cl)C=CC=C3Cl)=C4)=O)=C4C=N2)=C1 |
| EOS-AX9291 | Cdk1/2 Inhibitor III | 443798-47-8 | C15H13F2N7O2S2 | 425.4 | NC1=NC(NC2=CC=C(S(N)(=O)=O)C=C2)=NN1C(NC3=C(F)C=CC=C3F)=S |
| EOS-AX9292 | 9,12-Octadecadiynoic Acid | 2012-14-8 | C18H28O2 | 276.4 | CCCCCCCCCCCCCCCCCC(=O)O |
| EOS-AX9293 | CCG-100602 | 1207113-88-9 | C21H17ClF6N2O2 | 478.8 | ClC(C=C1)=CC=C1NC(C(C2)CCCN2C(C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)=O)=O |
| EOS-AX9294 | Fialuridine | 69123-98-4 | C9H10FIN2O5 | 372.1 | OC[C@@H]1[C@@H](O)[C@H](F)[C@H](N2C=C(I)C(NC2=O)=O)O1 |
| EOS-AX9295 | BM 567 | 284464-77-3 | C18H28N4O5S | 412.5 | CCCCCNC(=O)NS(=O)(=O)c1cc(ccc1NC1CCCCC1)[N](=O)O |
| EOS-AX9296 | Seratrodast | 112665-43-7 | C22H26O4 | 354.4 | OC(CCCCCC(C1=CC=CC=C1)C(C(C(C)=C2C)=O)=C(C)C2=O)=O |
| EOS-AX9297 | GSK2981278 | 1474110-21-8 | C25H35NO5S | 461.6 | OCC1=CC(S(N(CC(C)C)C2=CC=C(CC)C=C2)(=O)=O)=CC=C1OCC3CCOCC3 |
| EOS-AX9298 | L-Leucine 4-methoxy-β-naphthylamide (hydrochloride) | 4467-68-9 | C17H22N2O2 • HCl | 322.8 | COC1=CC(NC([C@H](CC(C)C)N)=O)=CC2=CC=CC=C21.Cl |
| EOS-AX9299 | Eniporide | 176644-21-6 | C14H16N4O3S | 320.4 | CC1=C(C(NC(N)=N)=O)C=C(S(C)(=O)=O)C(N2C=CC=C2)=C1 |
| EOS-AX9300 | FPS-ZM1 | 945714-67-0 | C20H22ClNO | 327.9 | ClC1=CC=C(C(N(CC2=CC=CC=C2)C3CCCCC3)=O)C=C1 |
| EOS-AX9301 | Inotilone | 906366-79-8 | C12H10O4 | 218.2 | OC1=CC=C(/C=C2OC(C)=CC\2=O)C=C1O |
| EOS-AX9302 | Barnidipine (hydrochloride) | 104757-53-1 | C27H29N3O6 • HCl | 528 | CC1=C(C(O[C@@H]2CN(CC3=CC=CC=C3)CC2)=O)[C@H](C(C(OC)=O)=C(C)N1)C4=CC([N+]([O-])=O)=CC=C4.Cl |
| EOS-AX9303 | Sp-5,6-dichloro-cBIMPS (sodium salt) | 142439-96-1 | C12H10Cl2N2O5PS • Na | 419.1 | [S-][P@]1(OC[C@]2([H])[C@@]([C@@H](O)[C@H](N3C(C=C(Cl)C(Cl)=C4)=C4N=C3)O2)([H])O1)=O.[Na+] |
| EOS-AX9304 | AAL-993 | 269390-77-4 | C20H16F3N3O | 371.4 | O=C(NC1=CC=CC(C(F)(F)F)=C1)C2=CC=CC=C2NCC3=CC=NC=C3 |
| EOS-AX9305 | 9-cis-Retinoic Acid | 5300-03-8 | C20H28O2 | 300.44 | CC1(C)C(/C=C/C(C)=C\C=C\C(C)=C\C(O)=O)=C(C)CCC1 |
| EOS-AX9306 | BAY u3405 | 116649-85-5 | C21H21FN2O4S | 416.5 | O=S(N[C@H](CC1)CC2=C1N(CCC(O)=O)C3=CC=CC=C23)(C4=CC=C(F)C=C4)=O |
| EOS-AX9307 | 2,4-Diacetylphloroglucinol | 2161-86-6 | C10H10O5 | 210.2 | OC1=C(C(C)=O)C(O)=C(C(C)=O)C(O)=C1 |
| EOS-AX9308 | Dimethyl DL-Glutamate (hydrochloride) | 13515-99-6 | C7H13NO4 • HCl | 211.6 | COC(C(N)CCC(OC)=O)=O.Cl |
| EOS-AX9309 | Iso-Olomoucine | 101622-50-8 | C15H18N6O | 298.3 | OCCNC1=NC(N=CN2C)=C2C(NCC3=CC=CC=C3)=N1 |
| EOS-AX9310 | 5-hydroxy Tryptophol | 154-02-9 | C10H11NO2 | 177.2 | OCCC1=CNC2=C1C=C(O)C=C2 |
| EOS-AX9311 | MS049 (hydrochloride) | | C15H24N2O • 2HCl | 321.3 | CNCCN(CC1)CCC1OCC2=CC=CC=C2.Cl.Cl |
| EOS-AX9312 | L-Histidinol (hydrochloride) | 1596-64-1 | C6H11N3O • 2HCl | 214.1 | OC[C@@H](N)CC1=CNC=N1.Cl.Cl |
| EOS-AX9313 | SE 175 | 258278-64-7 | C16H13NO6S | 347.3 | COC(=O)c1ccccc1SC(=O)c1ccc(CO[N](=O)O)cc1 |
| EOS-AX9314 | Arachidonic Acid Leelamide | | C40H61NO | 571.9 | CC(C)C(C=C1)=CC2=C1[C@]3(C)[C@](CC2)([H])[C@@](CN([H])C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)(C)CCC3 |
| EOS-AX9315 | L-DOPA methyl ester (hydrochloride) | 1421-65-4 | C10H13NO4 • HCl | 247.7 | OC1=C(O)C=CC(C[C@H](N)C(OC)=O)=C1.Cl |
| EOS-AX9316 | Guanabenz (hydrochloride) | 23113-43-1 | C8H8Cl2N4 • HCl | 267.5 | ClC1=C(/C=N/NC(N)=N)C(Cl)=CC=C1.Cl |
| EOS-AX9317 | Oleyloxyethyl Phosphorylcholine | 84601-19-4 | C25H52NO5P | 477.7 | CCCCCCCC/C=C\CCCCCCCCOCCOP([O-])(OCC[N+](C)(C)C)=O |
| EOS-AX9318 | 1-Naphthyl 3,5-dinitrobenzoate | 93261-39-3 | C17H10N2O6 | 338.3 | O=C(C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1)OC2=CC=CC3=C2C=CC=C3 |
| EOS-AX9319 | Kanamycin A | 59-01-8 | C18H36N4O11 | 484.5 | N[C@H]([C@H]1O)[C@H](O)[C@@H](CO)O[C@]1([H])O[C@H]([C@H]2O)[C@H](N)C[C@H](N)[C@H]2OC3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O |
| EOS-AX9320 | Norgestimate | 35189-28-7 | C23H31NO3 | 369.5 | CC[C@@]12[C@](CC[C@@]2(OC(C)=O)C#C)([H])[C@]3([H])CCC4=C/C(CC[C@]4([H])[C@@]3([H])CC1)=N/O |
| EOS-AX9321 | 3'-Azido-3'-deoxythymidine β-D-glucuronide (sodium salt) | 133525-01-6 | C16H20N5O10 • Na | 465.4 | O=C([O-])[C@@H](O1)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC[C@@H]2[C@@H](N=[N+]=[N-])C[C@H](N3C=C(C)C(NC3=O)=O)O2.[Na+] |
| EOS-AX9322 | Cefonicid (sodium salt) | 61270-78-8 | C18H16N6O8S3 • 2Na | 586.5 | O=C(N[C@H]1[C@](SCC(CSC2=NN=NN2CS([O-])(=O)=O)=C3C([O-])=O)([H])N3C1=O)[C@H](O)C4=CC=CC=C4.[Na+].[Na+] |
| EOS-AX9323 | Pyocyanin | 85-66-5 | C13H10N2O | 210.2 | Cn1c2ccccc2nc2c(=O)cccc12 |
| EOS-AX9324 | Phthalazinone pyrazole | 880487-62-7 | C18H15N5O | 317.4 | O=C1C2=C(C=CC=C2)C(NC3=NNC(C)=C3)=NN1C4=CC=CC=C4 |
| EOS-AX9325 | L-Canaline | 496-93-5 | C4H10N2O3 | 134.1 | N[C@@H](CCON)C(O)=O |
| EOS-AX9326 | 1-(1-Naphthyl) piperazine (hydrochloride) | 104113-71-5 | C14H16N2 • HCl | 248.7 | C1(C(N2CCNCC2)=CC=C3)=C3C=CC=C1.Cl |
| EOS-AX9327 | Cl-Amidine (trifluoroacetate salt) | 1043444-18-3 | C14H19ClN4O2 • CF3CO2H | 424.8 | O=C(N[C@@H](CCCNC(CCl)=N)C(N)=O)C1=CC=CC=C1.FC(F)(C(O)=O)F |
| EOS-AX9328 | Pimozide | 2062-78-4 | C28H29F2N3O | 461.6 | FC1=CC=C(C(CCCN2CCC(N3C(NC4=C3C=CC=C4)=O)CC2)C5=CC=C(F)C=C5)C=C1 |
| EOS-AX9329 | Ophiobolin B | 5601-74-1 | C25H38O4 | 402.6 | C[C@@]12C[C@@]([H])([C@]3(/C(C=O)=C\C[C@]1([C@](O)(CC2)[C@H](CC/C=C(C)\C)C)[H])[H])[C@](CC3=O)(C)O |
| EOS-AX9330 | Estradiol 17-(β-D-Glucuronide) (sodium salt) | 15087-02-2 | C24H31O8 • Na | 470.5 | [H][C@@]12CCC3=CC(O)=CC=C3[C@@]1([H])CC[C@@]4(C)[C@@]2([H])CC[C@@H]4O[C@@]5([H])[C@H](O)[C@@H](O)[C@H](O)[C@@H](C([O-])=O)O5.[Na+] |
| EOS-AX9331 | Neoruscogenin | 17676-33-4 | C27H40O4 | 428.6 | C=C(CO1)CC[C@@]21O[C@@]3([H])C[C@@]4([H])[C@]5([H])CC=C6C[C@@H](O)C[C@@H](O)[C@]6(C)[C@@]5([H])CC[C@]4(C)[C@@]3([H])[C@@H]2C |
| EOS-AX9332 | p-nitro-Pifithrin-α | 389850-21-9 | C15H15N3O3S • HBr | 398.3 | N=C(S1)N(CC(C2=CC=C([N+]([O-])=O)C=C2)=O)C3=C1CCCC3.Br |
| EOS-AX9333 | NCT-503 | 1916571-90-8 | C20H23F3N4S | 408.5 | S=C(N1CCN(CC2=CC=C(C(F)(F)F)C=C2)CC1)NC3=NC(C)=CC(C)=C3 |
| EOS-AX9334 | 2-chloro-3-Deazaadenosine | 40656-71-1 | C11H13ClN4O4 | 300.7 | O[C@H]1[C@H](N2C=NC3=C2C=C(Cl)N=C3N)O[C@H](CO)[C@H]1O |
| EOS-AX9335 | BQCA | 338747-41-4 | C18H15NO4 | 309.3 | COC1=CC=C(CN2C(C=CC=C3)=C3C(C(C(O)=O)=C2)=O)C=C1 |
| EOS-AX9336 | Pyrintegrin | 1228445-38-2 | C23H25N5O3S | 451.5 | OC1=CC2=C(C=C1)N(C3=CC=NC(NC4=CC=C(S(NCC5CC5)(=O)=O)C=C4)=N3)CCC2 |
| EOS-AX9337 | BayCysLT2 | 712313-33-2 | C34H39NO8 | 589.7 | O=C(NC1CCCC(C(O)=O)C1)C2=CC(C(O)=O)=CC=C2OCCCC(C=C3)=CC=C3OCCCCOC4=CC=CC=C4 |
| EOS-AX9338 | Pregnenolone Carbonitrile | 1434-54-4 | C22H31NO2 | 341.5 | O[C@H](C1)CC[C@@]2(C)C1=CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])C[C@@H](C#N)[C@@H]4C(C)=O |
| EOS-AX9339 | BW A868C | 118675-50-6 | C25H37N3O5 | 459.6 | O=C1C(CCCCCCC(O)=O)N(NCC(O)C2CCCCC2)C(N1CC3=CC=CC=C3)=O |
| EOS-AX9340 | JGB1741 | 1256375-38-8 | C27H24N2O2S | 440.6 | OC1=C(/C=N/C2=C(C(NCC3=CC=CC=C3)=O)C(CCCC4)=C4S2)C(C=CC=C5)=C5C=C1 |
| EOS-AX9341 | Ferulenol | 6805-34-1 | C24H30O3 | 366.5 | O=C1C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)=C(O)C2=CC=CC=C2O1 |
| EOS-AX9342 | Estradiol 3-(β-D-Glucuronide) (sodium salt) | 14982-12-8 | C24H31O8 • Na | 470.5 | [O-]C([C@H]([C@@H](O)[C@H](O)[C@H]1O)O[C@H]1OC2=CC=C3C(CC[C@]4([H])[C@]3([H])CC[C@@]5(C)[C@@]4([H])CC[C@@H]5O)=C2)=O.[Na+] |
| EOS-AX9343 | Cantharidic Acid (sodium salt) | 1465-77-6 | C10H12O5 • 2Na | 258.2 | OC([C@@]1(C)[C@](C(O)=O)(C)[C@@H]2CC[C@H]1O2)=O.[Na+].[Na+] |
| EOS-AX9344 | ONO-8711 | 216158-34-8 | C22H30ClNO4S | 439.2 | ClC1=CC(C)=C(S(N([H])C[C@@H](C2CCC3CC2)[C@H]3/C=C\CCCC(O)=O)(=O)=O)C=C1 |
| EOS-AX9345 | Ivermectin B1a | 71827-03-7 | C48H74O14 | 875.1 | C/C([C@@H](O[C@@]1([H])C[C@H](OC)[C@@H](O[C@]2([H])O[C@@H](C)[C@H](O)[C@@H](OC)C2)[C@H](C)O1)[C@@H](C)/C=C/C=C(CO3)/[C@@]([C@@]3([H])[C@H](O)C(C)=C4)(O)[C@]4([H])C5=O)=C\C[C@]6([H])C[C@@](O5)([H])C[C@]7(CC[C@H](C)[C@]([C@H](CC)C)([H])O7)O6 |
| EOS-AX9346 | Berninamycin A | 58798-97-3 | C51H51N15O15S | 1146.1 | O=C(NC(C(NC(C(N)=O)=C)=O)=C)C1=CC=C(C2=NC(C(N[C@]([C@@H](C)O)([H])C(N/C(C3=NC4=C(C)O3)=C\C)=O)=O)=CS2)C(C5=COC(C(NC(C(NC(C6=C(C)OC(C(NC([C@@H](NC(C(NC4=O)=C)=O)C(C)(O)C)=O)=C)=N6)=O)=C)=O)=C)=N5)=N1 |
| EOS-AX9347 | R-Palmitoyl-(1-methyl) Ethanolamide | 142128-47-0 | C19H39NO2 | 313.5 | CCCCCCCCCCCCCCCC(=O)N[C@H](C)CO |
| EOS-AX9348 | Cefoperazone (sodium salt) | 62893-20-3 | C25H26N9O8S2 • Na | 667.7 | CCN(CCN(C(N[C@H](C1=CC=C(O)C=C1)C(N[C@@H]2C(N3[C@]2([H])SCC(CSC4=NN=NN4C)=C3C([O-])=O)=O)=O)=O)C5=O)C5=O.[Na+] |
| EOS-AX9349 | Milbemycin D | 77855-81-3 | C33H48O7 | 556.7 | O=C([C@@]1([H])[C@@]2(O)[C@@]3([H])[C@H](O)C(C)=C1)O[C@@]4([H])C[C@](C/C=C(C)/C[C@@H](C)/C=C/C=C2\CO3)([H])O[C@]5(O[C@H](C(C)C)[C@@H](C)CC5)C4 |
| EOS-AX9350 | VU0359595 | 1246303-14-9 | C25H29BrN4O2 | 497.4 | C[C@H](NC([C@@H]1C[C@H]1C2=CC=CC=C2)=O)CN3CCC(N4C(NC5=C4C=CC(Br)=C5)=O)CC3 |
| EOS-AX9351 | Ulixertinib (hydrochloride) | | C21H22Cl2N4O2 • HCl | 469.8 | CC(C)NC1=CC(C2=CNC(C(N[C@H](CO)C3=CC(Cl)=CC=C3)=O)=C2)=C(Cl)C=N1.Cl |
| EOS-AX9352 | 2-fluoro Palmitic Acid | 16518-94-8 | C16H31FO2 | 274.4 | CCCCCCCCCCCCCCC(F)C(=O)O |
| EOS-AX9353 | MF498 | 915191-42-3 | C32H33N3O7S | 603.7 | O=C1N(C2=C(C)C=C(CS(NC(CC3=CC=CC=C3OC)=O)(=O)=O)C=C2)CC4=C(OCC)C5=C(C=CC=N5)C(OCC)=C41 |
| EOS-AX9354 | Resorcinolnaphthalein | 41307-63-5 | C24H14O5 | 382.4 | Oc1ccc2c(c1)Oc1cc(O)ccc1C12OC(=O)c2cccc3cccc1c23 |
| EOS-AX9355 | Bicyclomycin Benzoate | 37134-40-0 | C19H22N2O8 | 406.4 | O=C1[C@@](O)(NC2=O)C(CCO[C@]2([C@@H](O)[C@@](C)(O)COC(C3=CC=CC=C3)=O)N1)=C |
| EOS-AX9356 | Misonidazole | 13551-87-6 | C7H11N3O4 | 201.2 | OC(COC)CN1C=CN=C1[N+]([O-])=O |
| EOS-AX9357 | Teicoplanin A2-2 | 91032-26-7 | C88H97Cl2N9O33 | 1879.7 | O[C@@H]([C@H](O)[C@@H](CO)O1)[C@H](O)[C@H]1OC2=CC(O)=CC([C@@H](C(O)=O)NC([C@@]([C@@H](C3=CC(Cl)=C(OC4=CC5=CC(OC6=CC=C7C=C6Cl)=C4O[C@H]8[C@H](NC(CCCCCCC(C)C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O8)C=C3)O[C@]9([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9NC(C)=O)([H] |
| EOS-AX9358 | TBCA | 934358-00-6 | C9H4Br4O2 | 463.7 | BrC1=C(Br)C(Br)=C(Br)C=C1/C=C/C(O)=O |
| EOS-AX9359 | Rilmenidine (hemifumarate) | 207572-68-7 | C10H16N2O • 1/2C4H4O4 | 238.3 | OC(/C=C/C(O)=O)=O.C1(NC(C2CC2)C3CC3)=NCCO1.C4(NC(C5CC5)C6CC6)=NCCO4 |
| EOS-AX9360 | Sitagliptin (phosphate) | 654671-78-0 | C16H15F6N5O • H3PO4 | 505.3 | FC1=CC(C[C@@H](N)CC(N2CC3=NN=C(C(F)(F)F)N3CC2)=O)=C(F)C=C1F |
| EOS-AX9361 | Muscone | 541-91-3 | C16H30O | 238.4 | O=C1CCCCCCCCCCCCC(C)C1 |
| EOS-AX9362 | 5,15-DPP | 22112-89-6 | C32H22N4 | 462.6 | C1(C=C/2)=NC2=C/C3=CC=C(/C(C4=CC=CC=C4)=C5N=C(/C=C6N/C(C=C\6)=C1/C7=CC=CC=C7)C=C\5)N3 |
| EOS-AX9363 | Hemin chloride | 16009-13-5 | C34H30ClFeN4O4 • 2H | 652 | [O-]C(CCC1=C(C=C2[N]3=C4C(C)=C2CCC([O-])=O)[N-]([Fe+3]35([Cl-])[N]6=C7C=C(C(C=C)=C8C)[N-]5C8=C4)C(C=C6C(C=C)=C7C)=C1C)=O.[H+].[H+] |
| EOS-AX9364 | Muraglitazar | 331741-94-7 | C29H28N2O7 | 516.5 | O=C(OC1=CC=C(OC)C=C1)N(CC(O)=O)CC2=CC=C(C=C2)OCCC3=C(C)OC(C4=CC=CC=C4)=N3 |
| EOS-AX9365 | Chlorcyclizine (hydrochloride) | 14362-31-3 | C18H21ClN2 • HCl | 337.3 | CN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl |
| EOS-AX9366 | Lofexidine (hydrochloride) | 21498-08-8 | C11H12Cl2N2O • HCl | 295.6 | ClC1=CC=CC(Cl)=C1OC(C)C2=NCCN2.Cl |
| EOS-AX9367 | Cefadroxil (hydrate) | 66592-87-8 | C16H17N3O5S • H2O | 381.4 | OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@]2([H])SCC(C)=C3C(O)=O)=O)=O)C=C1.O |
| EOS-AX9368 | MEG (sulfate) | 3979-00-8 | [C3H9N3S]2 · H2SO4 | 336.4 | N/C(N([H])CCS)=N/[H].O=S(O)(O)=O |
| EOS-AX9369 | 2',5'-dideoxy Adenosine | 6698-26-6 | C10H13N5O2 | 235.2 | C[C@@H]1[C@@H](O)C[C@H](N2C=NC3=C2N=CN=C3N)O1 |
| EOS-AX9370 | Cdk4/6 Inhibitor IV | 359886-84-3 | C27H32N6O | 456.6 | CCNC1=NC(NC2=CC=C(N(CC3=CC=CC=C3)C=C4)C4=C2)=NC(N[C@H]5CC[C@H](O)CC5)=C1 |
| EOS-AX9371 | PRL-3 Inhibitor | 893449-38-2 | C17H11Br2NO2S2 | 485.2 | BrC1=CC=C(OCC2=C(Br)C=CC=C2)C(/C=C3C(NC(S\3)=S)=O)=C1 |
| EOS-AX9372 | 24(S)-hydroxy Cholesterol | 474-73-7 | C27H46O2 | 402.7 | O[C@@H]1CC2=CC[C@]3([H])[C@@](CC[C@]4([C@@]3([H])CC[C@]4([H])[C@@H](CC[C@H](O)C(C)C)C)C)([H])[C@](C)2CC1 |
| EOS-AX9373 | Azaserine | 115-02-6 | C5H7N3O4 | 173.1 | O=C(C=[N+]=[N-])OC[C@H](N)C(O)=O |
| EOS-AX9374 | CP21R7 | 125314-13-8 | C19H15N3O2 | 317.3 | NC1=CC=CC(C(C(N2)=O)=C(C3=CN(C)C4=C3C=CC=C4)C2=O)=C1 |
| EOS-AX9375 | 4-iodo-SAHA | 1219807-87-0 | C14H19IN2O3 | 390.2 | IC1=CC=C(NC(CCCCCCC(NO)=O)=O)C=C1 |
| EOS-AX9376 | Dihydrodaidzein | 17238-05-0 | C15H12O4 | 256.3 | OC(C=C1)=CC=C1C2C(C3=CC=C(O)C=C3OC2)=O |
| EOS-AX9377 | TS 155-2 | 1314486-37-7 | C39H60O11 | 704.9 | C[C@H]([C@]1(O)O[C@H](C(C)C)[C@@H](C)[C@H](OC(/C=C/C(O)=O)=O)C1)[C@H](O)[C@@H]([C@](OC(/C(C)=C/C(C)=C/[C@@H](C)[C@@H](O)[C@@H](C)C2)=O)([H])[C@H](/C=C/C=C2\C)OC)C |
| EOS-AX9378 | CEP-28122 | 1022958-60-6 | C28H35ClN6O3 | 539.1 | COC1=C(NC2=NC=C(Cl)C(N[C@@H]3[C@H](C4)C=C[C@H]4[C@@H]3C(N)=O)=N2)C=CC5=C1CC[C@@H](N6CCOCC6)CC5 |
| EOS-AX9379 | LHW090-A7 | | C20H21ClNO4 • Na | 397.8 | ClC1=CC=CC(C2=CC=C(C[C@H](N[C@H](C(OCC)=O)C)C([O-])=O)C=C2)=C1.[Na+] |
| EOS-AX9380 | Tetromycin A | 180027-83-2 | C36H48O6 | 576.8 | CC1=C[C@@]2([H])[C@@]([C@@](C(C3=C4O)=O)(C)[C@]1([H])/C(C)=C/CC/C(C)=C/[C@@]5(C)[C@@]4(OC3=O)C[C@@H](C)C(C)=C5)([H])[C@@H](C)CC[C@@H]2OC(C)=O |
| EOS-AX9381 | (3S,5S)-Atorvastatin (sodium salt) | 1428118-38-0 | C33H34FN2O5 • Na | 580.6 | O=C(C1=C(C(C)C)N(CC[C@H](O)C[C@H](O)CC([O-])=O)C(C2=CC=C(F)C=C2)=C1C3=CC=CC=C3)NC4=CC=CC=C4.[Na+] |
| EOS-AX9382 | (±)-4-hydroxy Propranolol (hydrochloride) | 14133-90-5 | C16H21NO3 • HCl | 311.8 | OC1=CC=C(OCC(O)CNC(C)C)C2=C1C=CC=C2.Cl |
| EOS-AX9383 | Triclosan | 3380-34-5 | C12H7Cl3O2 | 289.5 | ClC1=C(OC2=CC=C(Cl)C=C2O)C=CC(Cl)=C1 |
| EOS-AX9384 | CJ-42794 | 847728-01-2 | C22H17ClFNO4 | 413.8 | FC1=CC=C(OC2=C(C(N[C@@H](C)C3=CC=C(C(O)=O)C=C3)=O)C=C(Cl)C=C2)C=C1 |
| EOS-AX9385 | Fucoidan | 9072-19-9 | (C6H9O3SO3)n | | C[C@]1([H])[C@@H](OC)[C@H](O)[C@H](OS(O)(=O)=O)[C@H](C)O1 |
| EOS-AX9386 | Pyoluteorin | 25683-07-2 | C11H7Cl2NO3 | 272.1 | OC1=CC=CC(O)=C1C(C2=CC(Cl)=C(Cl)N2)=O |
| EOS-AX9387 | Olomoucine | 101622-51-9 | C15H18N6O | 298.3 | OCCNc1nc(NCc2ccccc2)c2ncn(C)c2n1 |
| EOS-AX9388 | Fusapyrone | 156856-31-4 | C34H54O9 | 606.8 | O[C@H]1C[C@@H](CO)O[C@@H](C2=C(O)OC(C(C)(C)C(O)/C=C/C(C)=C/C(CO)/C=C(C)\CC(C)CCCCCC)=CC2=O)[C@@H]1O |
| EOS-AX9389 | 6α-methyl-11β-Hydroxyprogesterone | 2668-66-8 | C22H32O3 | 344.5 | C[C@@]12[C@](CC[C@@H]2C(C)=O)([H])[C@]3([H])C[C@H](C)C4=CC(CC[C@]4(C)[C@@]3([H])[C@@H](O)C1)=O |
| EOS-AX9390 | (±)-Baclofen | 1134-47-0 | C10H12ClNO2 | 213.7 | ClC1=CC=C(C(CN)CC(O)=O)C=C1 |
| EOS-AX9391 | Asoxime (chloride) | 34433-31-3 | C14H16N4O3 • 2Cl | 359.2 | O/N=C\C1=CC=CC=[N+]1COC[N+]2=CC=C(C(N)=O)C=C2.[Cl-].[Cl-] |
| EOS-AX9392 | all-trans Retinal | 116-31-4 | C20H28O | 284.4 | CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C([H])=O)C(C)(C)CCC1 |
| EOS-AX9393 | W123 | 1345982-24-2 | C17H26N2O3 | 306.4 | OC(=O)CCNCC(=O)Nc1cccc(CC2CCCCC2)c1 |
| EOS-AX9394 | NG-amino-L-Arginine (hydrochloride) | 1031799-40-2 | C6H15N5O2 • HCl | 225.7 | NNC(NCCC[C@H](N)C(O)=O)=N.Cl |
| EOS-AX9395 | VLX600 | 327031-55-0 | C17H15N7 | 317.4 | C/C(C1=NC=CC=C1)=N/NC2=NC3=C(C(C=CC=C4C)=C4N3)N=N2 |
| EOS-AX9396 | PPM-18 | 65240-86-0 | C17H11NO3 | 277.3 | O=C(NC1=CC(=O)c2ccccc2C1=O)c1ccccc1 |
| EOS-AX9397 | Nortriptyline (hydrochloride) | 894-71-3 | C19H21N • HCl | 299.8 | CNCC/C=C1C2=C(C=CC=C2)CCC3=C/1C=CC=C3.Cl |
| EOS-AX9398 | MMP Inhibitor II | 203915-59-7 | C21H27N3O8S2 | 513.6 | COC1=CC=C(S(N2CC(C)(C)CN(S(C3=CC=C(OC)C=C3)(=O)=O)C2C(NO)=O)(=O)=O)C=C1 |
| EOS-AX9399 | Eicosapentaenoyl Serotonin | 199875-71-3 | C30H40N2O2 | 460.7 | O=C(NCCC1=CNC2=CC=C(O)C=C12)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC |
| EOS-AX9400 | Vacuolin-1 | 351986-85-1 | C26H24IN7O | 577.4 | IC1=CC(/C=N/NC2=NC(N(C3=CC=CC=C3)C4=CC=CC=C4)=NC(N5CCOCC5)=N2)=CC=C1 |
| EOS-AX9401 | Maduramicin | 79356-08-4 | C47H80O17 | 917.1 | CO[C@@H]1[C@@H](OC)[C@H](C)O[C@@](O[C@@H]2[C@@]([C@]3(C)CC[C@@]([C@@]4(C)O[C@@]5(C[C@H](O)[C@@H](C)[C@]([C@@H](C)[C@]6([H])O[C@@](CC(O)=O)(O)[C@@H](C)[C@H](OC)[C@H]6OC)([H])O5)CC4)([H])O3)([H])O[C@]([C@]7([H])[C@@H](C)C[C@@H](C)[C@@](C)(O)O7)([H])C2) |
| EOS-AX9402 | Mebendazole | 31431-39-7 | C16H13N3O3 | 295.3 | O=C(C1=CC=C(NC(NC(OC)=O)=N2)C2=C1)C3=CC=CC=C3 |
| EOS-AX9403 | HMB-Val-Ser-Leu-VE | 862891-04-1 | C26H39N3O7 | 505.6 | OC1=CC=CC(C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CC(C)C)/C=C/C(OCC)=O)=O)=O)=O)=C1C |
| EOS-AX9404 | N-Isopropylnoratropine | 22235-81-0 | C19H27NO3 | 317.4 | O=C(C(CO)C1=CC=CC=C1)O[C@H]2C[C@H]3CC[C@H](N3C(C)C)C2 |
| EOS-AX9405 | NI-57 | 1883548-89-7 | C19H17N3O4S | 383.4 | COC1=CC(C#N)=CC=C1S(NC2=CC=C(N(C)C(C(C)=C3)=O)C3=C2)(=O)=O |
| EOS-AX9406 | Pirinixic Acid Aminothiazole | 1492060-44-2 | C25H25ClN4O2S | 513.1 | ClC1=NC(SC(CCCCCC)C(O)=O)=NC(NC2=NC(C3=CC=C(C=CC=C4)C4=C3)=CS2)=C1 |
| EOS-AX9407 | AG-041R | 159883-95-1 | C31H36N4O5 | 544.7 | CC1=CC=C(NC(N[C@@]2(C3=C(C=CC=C3)N(CC(OCC)OCC)C2=O)CC(NC4=CC=C(C)C=C4)=O)=O)C=C1 |
| EOS-AX9408 | 25(R)-27-hydroxy Cholesterol | 20380-11-4 | C27H46O2 | 402.7 | O[C@@H]1CC2=CC[C@]3([H])[C@@](CC[C@]4([C@@]3([H])CC[C@]4([H])[C@@H](CCC[C@@H](C)CO)C)C)([H])[C@](C)2CC1 |
| EOS-AX9409 | STAT5 Inhibitor | 285986-31-4 | C16H11N3O3 | 293.3 | O=C(N/N=C/C1=COC(C=CC=C2)=C2C1=O)C3=CC=CN=C3 |
| EOS-AX9410 | N-3-oxo-dodecanoyl-L-Homoserine lactone | 168982-69-2 | C16H27NO4 | 297.4 | CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O |
| EOS-AX9411 | 5-fluoro 203 | 260443-89-8 | C14H11FN2S | 258.3 | FC1=CC=C(SC(C2=CC=C(N)C(C)=C2)=N3)C3=C1 |
| EOS-AX9412 | ML-095 (hydrochloride) | 1135318-57-8 | C13H14N2O3 • HCl | 282.7 | OC1=CC=C(C(CN2C=CN=C2CC)=O)C=C1O.Cl |
| EOS-AX9413 | Imipramine (hydrochloride) | 113-52-0 | C19H24N2 • HCl | 316.9 | CN(C)CCCN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.Cl |
| EOS-AX9414 | 2',3',5'-triacetyl-5-Azacytidine | 10302-78-0 | C14H18N4O8 | 370.3 | O=C1N([C@@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H]2OC(C)=O)C=NC(N)=N1 |
| EOS-AX9415 | SP 141 | 1253491-42-7 | C22H16N2O | 324.4 | COC1=CC2=C(C=C1)NC(C2=CC=N3)=C3C4=C(C=CC=C5)C5=CC=C4 |
| EOS-AX9416 | Moxalactam (sodium salt) | 64953-12-4 | C20H18N6O9S • 2Na | 564.4 | OC1=CC=C([C@@H](C([O-])=O)C(N[C@@]2(OC)[C@](OCC(CSC3=NN=NN3C)=C4C([O-])=O)([H])N4C2=O)=O)C=C1.[Na+].[Na+] |
| EOS-AX9417 | JNJ-42165279 | 1346528-50-4 | C18H17ClF2N4O3 | 410.8 | ClC1=CC=NC=C1NC(N2CCN(CC3=CC=C(OC(F)(F)O4)C4=C3)CC2)=O |
| EOS-AX9418 | β-acetyl-Boswellic Acid | 5968-70-7 | C32H50O4 | 498.7 | C[C@]1(C(O)=O)[C@H](OC(C)=O)CC[C@]2(C)[C@@]3([H])CC=C4[C@](CC[C@]5(C)[C@@]4([H])[C@@H](C)[C@H](C)CC5)(C)[C@]3(C)CC[C@]21[H] |
| EOS-AX9419 | | | | | |
| EOS-AX9420 | Bradykinin (acetate) | 6846-03-3 | C50H73N15O11 • XC2H4O2 | 1120.3 | O=C([C@H](CCC1)N1C([C@@H](N)CCCNC(N)=N)=O)N(CCC2)[C@@H]2C(NCC(N[C@H](C(N[C@@H](CO)C(N(CCC3)[C@@H]3C(N[C@H](C(N[C@H](C(O)=O)CCCNC(N)=N)=O)CC4=CC=CC=C4)=O)=O)=O)CC5=CC=CC=C5)=O)=O.CC(O)=O |
| EOS-AX9421 | Sulfaphenazole | 526-08-9 | C15H14N4O2S | 314.4 | NC1=CC=C(S(NC2=CC=NN2C3=CC=CC=C3)(=O)=O)C=C1 |
| EOS-AX9422 | OU749 | 519170-13-9 | C16H15N3O3S2 | 361.4 | COC1=CC=C(CC2=NN=C(NS(C3=CC=CC=C3)(=O)=O)S2)C=C1 |
| EOS-AX9423 | Clorgyline (hydrochloride) | 17780-75-5 | C13H15Cl2NO • HCl | 308.6 | ClC1=CC=C(OCCCN(C)CC#C)C(Cl)=C1.Cl |
| EOS-AX9424 | Edrophonium (chloride) | 116-38-1 | C10H16NO • Cl | 201.7 | OC1=CC([N+](C)(C)CC)=CC=C1.[Cl-] |
| EOS-AX9425 | KIN-59 | 4152-77-6 | C29H26N4O5 | 510.5 | O[C@H]1[C@@H](O)[C@H](N2C=NC3=C2N=CNC3=O)O[C@@H]1COC(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6 |
| EOS-AX9426 | Arachidonoyl amide | 85146-53-8 | C20H33NO | 303.5 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N |
| EOS-AX9427 | Doxepin (hydrochloride) | 1229-29-4 | C19H21NO • HCl | 315.8 | CN(C)CC/C=C1C2=C(C=CC=C2)COC3=C/1C=CC=C3.Cl |
| EOS-AX9428 | (−)-trans-C75 | 1234694-22-4 | C14H22O4 | 254.3 | CCCCCCCC[C@H](OC1=O)[C@H](C(O)=O)C1=C |
| EOS-AX9429 | (R)-Lisofylline | 100324-81-0 | C13H20N4O3 | 280.3 | O=C(N(C)C1=C2N(C)C=N1)N(CCCC[C@H](O)C)C2=O |
| EOS-AX9430 | (S)-Lisofylline | 100324-80-9 | C13H20N4O3 | 280.3 | O=C(N(C)C1=C2N(C)C=N1)N(CCCC[C@@H](O)C)C2=O |
| EOS-AX9431 | CRT5 | 1034297-58-9 | C28H30N4O2 | 454.6 | CCOC1=CC=C2C(C=CC(C3=CC(C4=CC(C(NCCN(C)C)=O)=CC=C4)=CN=C3N)=C2)=C1 |
| EOS-AX9432 | Oleoyl Serotonin | 1002100-44-8 | C28H44N2O2 | 440.1 | O=C(NCCC1=CNC2=CC=C(O)C=C12)CCCCCCC/C=C\CCCCCCCC |
| EOS-AX9433 | Palmitoyl Serotonin | 212707-51-2 | C26H42N2O2 | 414.6 | CCCCCCCCCCCCCCCC(NCCC1=CNC2=CC=C(O)C=C12)=O |
| EOS-AX9434 | Stearoyl Serotonin | 67964-87-8 | C28H46N2O2 | 442.7 | O=C(NCCC1=CNC2=CC=C(O)C=C12)CCCCCCCCCCCCCCCCC |
| EOS-AX9435 | Docosahexaenoyl Serotonin | 283601-58-1 | C32H42N2O2 | 486.7 | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(NCCC1=CNC2=CC=C(O)C=C12)=O |
| EOS-AX9436 | Epiallopregnanolone | 567-01-1 | C21H34O3 | 334.5 | C[C@@]12[C@](CC[C@@H]2C(CO)=O)([H])[C@]3([H])CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC1 |
| EOS-AX9437 | Ristocetin A (sulfate) | 90831-71-3 | C95H112N8O44 • SO4 | 2166 | CC1C(O)C(N)CC(OC2C3C(NC(C(OC)=O)C4=CC(O)=CC(OC5C(O)C(O)C(O)C(CO)O5)=C4C6=C(O)C=CC(C(NC(C7C8=CC(OC9=CC=C(C(O)C%10C(NC(C(N7)=O)C%11=CC(OC%12=C(O)C=CC(C(N)C(N%10)=O)=C%12)=C(C)C(O)=C%11)=O)C=C9)=C(OC%13C(OC%14C(OC%15C(O)C(O)C(O)CO%15)C(O)C(O)C(CO)O%14)C(O)C( |
| EOS-AX9438 | ML-265 | 1221186-53-3 | C17H16N4O2S2 | 372.5 | CS(C1=CC(N2C)=C(S1)C3=C2C(N(CC4=CC(N)=CC=C4)N=C3)=O)=O |
| EOS-AX9439 | Leucomycin A1 | 16846-34-7 | C40H67NO14 | 786 | O=C1C[C@H]([C@@H]([C@H]([C@H](C[C@H]([C@H](/C=C/C=C/C[C@H](O1)C)O)C)CC=O)O[C@@]2(O[C@@H]([C@H]([C@@H]([C@H]2O)N(C)C)O[C@]3(C[C@@](O)([C@H]([C@@H](O3)C)OC(CC(C)C)=O)C)[H])C)[H])OC)O |
| EOS-AX9440 | Cefazolin (sodium salt) | 27164-46-1 | C14H13N8O4S3 • Na | 476.5 | O=C(CN1N=NN=C1)N[C@H](C2=O)[C@]3([H])N2C(C([O-])=O)=C(CSC4=NN=C(C)S4)CS3.[Na+] |
| EOS-AX9441 | Arphamenine B (hemisulfate) | 144110-38-3 | C16H24N4O4 • 1/2H2SO4 | 385.4 | O=C([C@@H](N)CCCNC(N)=N)C[C@H](C(O)=O)CC1=CC=C(O)C=C1.OS(O)(=O)=O |
| EOS-AX9442 | NQTrp | 185351-19-3 | C21H16N2O4 | 360.4 | O=C(C=C(N[C@H](C(O)=O)CC1=CNC2=C1C=CC=C2)C3=O)C4=C3C=CC=C4 |
| EOS-AX9443 | HZ52 | 1077626-51-7 | C24H26ClN3O2S | 456 | ClC1=CC(NC2=CC=C(C3=CC=CC=C3)C=C2)=NC(SC(CCCCCC)C(O)=O)=N1 |
| EOS-AX9444 | Monazomycin | 11006-31-8 | C72H133NO22 | 1364.8 | OC(CC(C(C(C(O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)C(CO)O1)/C=C(C)/C(O)C(C)/C=C(C)/C(O)C(C)/C=C/CCC(O)C(C)C(O)CCCCCC2=O)O)C)O)/C=C/C(C)C(O)C(C)CCC(O)CC(O)C(C)C(O)C(C)C(O)CC(O)CC(O)C(C)C(O2)C(C)CCCCCCN |
| EOS-AX9445 | GSK-LSD1 (hydrochloride) | | C14H20N2 • 2HCl | 289.2 | [C@H]1(C2=CC=CC=C2)[C@H](NC3CCNCC3)C1.Cl.Cl |
| EOS-AX9446 | Germicidin B | 150973-78-7 | C10H14O3 | 182.2 | O=C1OC(C(C)C)=CC(O)=C1CC |
| EOS-AX9447 | OXA-01 | 936889-68-8 | C21H20CIN5O2 | 409.9 | OC([C@H]1CC[C@H](C2=NC(C3=CC4=C(C(Cl)=CC=C4)N3)=C5N2C=CN=C5N)CC1)=O |
| EOS-AX9448 | 21-hydroxy Oligomycin A | 102042-09-1 | C45H74O12 | 807.1 | O=C([C@@H](C)[C@H](O)[C@@H](C)/C=C/1)[C@H](C)[C@@H](O)[C@H](C)C([C@@](O)(C)[C@@H](O)[C@H](C)C/C=C/C=C/[C@H](CC)[C@H](O)C[C@@]2([H])[C@@H](C)[C@@]([C@H](C)[C@@]3(CC[C@H](C)[C@@](C[C@H](O)C)([H])O3)O2)([H])OC1=O)=O |
| EOS-AX9449 | Enterocin | 59678-46-5 | C22H20O10 | 444.4 | O=C1[C@@]2(O)[C@@]([C@@H](C(O3)=CC(OC)=CC3=O)[C@]4(O)[C@@H]2C(C5=CC=CC=C5)=O)(O)C[C@@]([C@]([H])4O)([H])O1 |
| EOS-AX9450 | Ataciguat | 254877-67-3 | C21H19Cl2N3O6S3 | 576.5 | O=S(N1CCOCC1)(C2=CC=C(NC(C3=CC(Cl)=CC=C3NS(C4=CC=C(Cl)S4)(=O)=O)=O)C=C2)=O |
| EOS-AX9451 | Nitecapone | 116313-94-1 | C12H11NO6 | 265.2 | OC1=C([N+]([O-])=O)C=C(/C=C(C(C)=O)/C(C)=O)C=C1O |
| EOS-AX9452 | Anhydrochlortetracycline (hydrochloride) | 65490-24-6 | C22H21ClN2O7 • HCl | 497.3 | OC1=C2C(O)=CC=C(Cl)C2=C(C)C3=C1C([C@@](C(C(C(N)=O)=C(O)[C@H]4N(C)C)=O)(O)[C@@]4([H])C3)=O.Cl |
| EOS-AX9453 | Phomopsin A | 64925-80-0 | C36H45ClN6O12 | 789.2 | OC(/C(NC(/C(NC([C@H]1N(C([C@@H]2NC([C@H](C(C)=C)NC([C@@H](NC)[C@H](C3=CC(O[C@@]2(CC)C)=C(O)C(Cl)=C3)O)=O)=O)=O)CC=C1)=O)=C(CC)/C)=O)=C\C(O)=O)=O |
| EOS-AX9454 | BRD7116 | 329059-55-4 | C28H36N2O4S | 496.7 | O=S(C1=CC=C(NC(C2C(C)(C)C2(C)C)=O)C=C1)(C3=CC=C(NC(C4C(C)(C)C4(C)C)=O)C=C3)=O |
| EOS-AX9455 | Luotonin F | 244616-85-1 | C18H11N3O2 | 301.3 | O=C1NC(C(C2=CC(C=CC=C3)=C3N=C2)=O)=NC4=CC=CC=C41 |
| EOS-AX9456 | UMB-32 | 1635437-39-6 | C21H23N5O | 361.4 | CC(C)(C)NC1=C(N=C2N1C=CN=C2)C3=CC=C(C4=C(C)ON=C4C)C=C3 |
| EOS-AX9457 | Sandramycin | 100940-65-6 | C60H76N12O16 | 1221.3 | O=C([C@@H](COC([C@@H](N(C(CN(C(CNC([C@@](CCCC1)([H])N1C2=O)=O)=O)C)=O)C)C(C)C)=O)NC(C3=NC(C=CC=C4)=C4C=C3O)=O)N(CCCC5)[C@]5([H])C(NCC(N(CC(N([C@H](C(OC[C@H]2NC(C6=NC(C=CC=C7)=C7C=C6O)=O)=O)C(C)C)C)=O)C)=O)=O |
| EOS-AX9458 | FTY720 Phosphate | 402615-91-2 | C19H34NO5P | 387.5 | CCCCCCCCC1=CC=C(CCC([NH3+])(COP([O-])(O)=O)CO)C=C1 |
| EOS-AX9459 | SQ 29,548 | 98672-91-4 | C21H29N3O4 | 387.5 | OC(=O)CCC/C=C\CC1C2CCC(O2)C1CNNC(=O)Nc1ccccc1 |
| EOS-AX9460 | RPI-1 | 269730-03-2 | C17H15NO4 | 279.3 | COC1=C(OC)C=C(/C(C(N2)=O)=C/C3=CC=C(O)C=C3)C2=C1 |
| EOS-AX9461 | 7α,25-dihydroxy Cholesterol | 64907-22-8 | C27H46O3 | 418.7 | O[C@@H]1C=C2C[C@@H](O)CC[C@]2(C)[C@]3([H])[C@]1([H])[C@@](CC[C@]4([H])[C@H](C)CCCC(C)(C)O)([H])[C@]4(C)CC3 |
| EOS-AX9462 | Celastramycin A | 491600-94-3 | C17H18Cl3NO3 | 390.7 | ClC1=CC(CCCCCC)=C(O)C(C(C2=CC(Cl)=C(Cl)N2)=O)=C1O |
